EP0107120B1 - Substituted aminoalcanol phospholipids and process for their preparation - Google Patents

Substituted aminoalcanol phospholipids and process for their preparation Download PDF

Info

Publication number
EP0107120B1
EP0107120B1 EP83109927A EP83109927A EP0107120B1 EP 0107120 B1 EP0107120 B1 EP 0107120B1 EP 83109927 A EP83109927 A EP 83109927A EP 83109927 A EP83109927 A EP 83109927A EP 0107120 B1 EP0107120 B1 EP 0107120B1
Authority
EP
European Patent Office
Prior art keywords
formula
compounds
ethanol
phosphocholin
benzyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
EP83109927A
Other languages
German (de)
French (fr)
Other versions
EP0107120A1 (en
Inventor
Hans-Heiner Dr. Lautenschläger
Harald Dr. Borbe
Gerrit Dr. Prop
Ferdinand Dr. Wirtz-Peitz
Ille-Stephanie Doppelfeld
Michael John Dr. Parnham
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
A Natterman und Cie GmbH
Original Assignee
A Natterman und Cie GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE19823239390 external-priority patent/DE3239390A1/en
Priority claimed from DE19823239388 external-priority patent/DE3239388A1/en
Application filed by A Natterman und Cie GmbH filed Critical A Natterman und Cie GmbH
Priority to AT83109927T priority Critical patent/ATE23164T1/en
Publication of EP0107120A1 publication Critical patent/EP0107120A1/en
Application granted granted Critical
Publication of EP0107120B1 publication Critical patent/EP0107120B1/en
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/06Phosphorus compounds without P—C bonds
    • C07F9/08Esters of oxyacids of phosphorus
    • C07F9/09Esters of phosphoric acids
    • C07F9/10Phosphatides, e.g. lecithin
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/06Phosphorus compounds without P—C bonds
    • C07F9/08Esters of oxyacids of phosphorus
    • C07F9/09Esters of phosphoric acids
    • C07F9/091Esters of phosphoric acids with hydroxyalkyl compounds with further substituents on alkyl

Definitions

  • the present invention relates to new substituted aminoalkanol phospholipids and processes for their preparation.
  • the compounds according to the invention correspond to the general formula in which X is an oxygen or sulfur atom and Y is the radical NR 1 R 2 or -OR 3 , where R 1 , R 2 can be identical or different and a saturated or unsaturated, straight-chain or branched alkyl radical having 1-20 carbon atoms, represent a benzyl radical, phenyl radical or hydrogen, and R 3 represents phenyl, benzyl or C 1-4 alkyl.
  • R 4 , R 5 , R 6 can be the same or different and stand for hydrogen or a lower alkyl radical with 1-4 carbon atoms.
  • 1 means an integer from 0-19, m an integer from 2-6, n an integer from 2-4.
  • the compounds according to the invention are very biologically active and can be used, for example, in pharmaceuticals and in crop protection the.
  • the new compounds show a strong pharmacological effect, in particular they have a hypotensive and immunoregulatory effect. They can therefore be used to treat high pressure, but also to treat inflammatory diseases and to treat atherosclerosis and tumors.
  • N-alkylaminoalkanols of the general formula II in which and m have the meaning given in the formula in an inert organic solvent such as ether, tetrahydrofuran, dioxane, acetone, chloroform, dimethylformamide with a benzyl halide or benzyl chloroformate, preferably in the presence of an auxiliary base such as pyridine, dimethylaminopyridine, triethylamine, alkali metal hydroxide , Alkaline earth oxide, converted to the compounds of general formula III.
  • an inert organic solvent such as ether, tetrahydrofuran, dioxane, acetone, chloroform, dimethylformamide with a benzyl halide or benzyl chloroformate
  • an auxiliary base such as pyridine, dimethylaminopyridine, triethylamine, alkali metal hydroxide , Alkaline earth oxide
  • the reaction can also be carried out in two phases, if necessary using a phase transfer catalyst.
  • the compounds II are accessible either by reacting the corresponding amines with ethylene oxide or by reducing N-acyl- ⁇ -aminoalkanols.
  • the compounds of the formal IV can also be prepared by using compounds of the formula III with phosphorus oxytrichloride and subsequently with an alkanediol of the formula VII HO- (CH 2 ) n -OH VII in which n has the meaning given in formula I, if appropriate using from auxiliary bases, such as triethylamine, and use of inert solvents, such as tetrahydrofuran, to give cyclic intermediates of the formula VIII wherein I, m, n and R 7 have the meanings given in formula IV, implemented [H. Eibl, Phospholipid Synthesis in Knight (Editor), Liposomes, Elsevier 1981, pp. 19-50].
  • the intermediates of formula VIII can also be prepared by compounds of formula III with a cyclic phosphorus compound of formal IX where n has the meaning given in formula I, in an inert organic solvent with the addition of an auxiliary base [NS Chandrakumar et al., Tetrahedron Lett. 23, 1043-46, (1982); Biochim. Biophys. Acta 711, 357-360, (1982)].
  • the intermediates VIII can be easily introduced into the compound, for example by treatment with an amine of the formula VI in an organic solvent, if appropriate under pressure gen IV formula (NT Thuong and P. Chabrier, Bull. Soc. Chim. Fr. 1974,667-671).
  • the compounds of general formula IV are hydrogenated with hydrogen in a suitable organic solvent, such as, for example, methanol, ethanol, ether, dioxane or mixtures thereof with one another and with water, with the benzyl group being split off, in the presence of a customary hydrogenation catalyst, such as, for example, palladium / activated carbon the compounds of the general formula X wherein R 4 , R 5 , R 6 , 1, m and n have the meanings given in formula I, arise.
  • a suitable organic solvent such as, for example, methanol, ethanol, ether, dioxane or mixtures thereof with one another and with water, with the benzyl group being split off
  • a customary hydrogenation catalyst such as, for example, palladium / activated carbon the compounds of the general formula X wherein R 4 , R 5 , R 6 , 1, m and n have the meanings given in formula I, arise.
  • the compounds of formula X are with carbonic acid derivatives of the formal XI or Xll wherein R 1 , R 2 and X have the meanings given in formal I, in bulk or in an inert organic solvent, such as dimethylformamide, chloroform, N-methylacetamide, optionally with the addition of a catalyst, such as dimethylaminopyridine or a base, such as Pyridine, triethylamine, in particular when using compounds of the formal XII, converted to the compounds of the formula according to the invention.
  • a catalyst such as dimethylaminopyridine or a base, such as Pyridine, triethylamine
  • N-alkylamino alcohols of the formula II are used in an inert organic solvent, such as e.g. Ether, tetrahydrofuran, dioxane, acetone, chloroform, dimethylformamide with benzyl chloroformate, phenyl chloroformate or alkyl chloroformate, preferably in the presence of an auxiliary base, such as e.g. Pyridine, dimethylaminopyridine, triethylamine, alkali metal hydroxide, alkaline earth metal oxide, converted to the compounds of the general formula XIII.
  • an inert organic solvent such as e.g. Ether, tetrahydrofuran, dioxane, acetone, chloroform, dimethylformamide with benzyl chloroformate, phenyl chloroformate or alkyl chloroformate
  • an auxiliary base such as e.g. Pyridine, dimethylaminopyridine, triethylamine,
  • the compounds of the formula XIII can be phosphorylated with dichlorophosphoric acid ca-halogenoalkyl esters of the formula V in an inert organic solvent, if appropriate using an auxiliary base, and subsequently by reaction with an amine of the formula VI in an inert organic solvent, if appropriate Pressure to convert to the compounds of Formula 1.
  • the compounds of the formula I can also be prepared by phosphorylating compounds of the formula III with phosphorus oxytrichloride and subsequently with an alkanediol of the formula VII or with compounds of the formula IX, if appropriate, using auxiliary bases such as triethylamine and using inert solvents such as tetrahydrofuran the cyclic intermediates of formula XIV wherein 1, m, n and R 3 have the meanings given in the formula.
  • the intermediate products XIV can be easily, e.g. by treatment with an amine of the formula VI, in an organic solvent, if appropriate under pressure, into the compounds of the formula I.
  • the compounds of formula 1 can also be prepared by reacting compounds of formula X with chloroformic acid esters in inert solvents, such as e.g. Chloroform, dimethylformamide, if necessary with the addition of an auxiliary base, e.g. Pyridine, triethylamine.
  • the starting compounds of formula V are e.g. in question: dichlorophosphoric acid 2-bromo-ethyl ester, dichlorophosphoric acid 2-chloroethyl ester, dichlorophosphoric acid 3-bromopropyl ester, dichlorophosphoric acid 4-bromobutyl ester.
  • the new substituted aminoalkanol phospholipids can e.g. processed into pharmaceutical preparations.
  • the pharmaceutical preparations are those for enteral, oral, rectal and parenteral administration, which contain the active pharmaceutical ingredients alone or together with a customary, pharmaceutically usable carrier material.
  • the pharmaceutical preparation of the active ingredient is advantageously in the form of single doses which are tailored to the desired administration, such as e.g. Tablets, coated tablets, capsules, suppositories, granules, solutions, emulsions or suspensions.
  • the dosage of the compounds is usually between 1-1000 mg per dose, preferably 1-10 mg per dose, and can be administered one or more times, preferably two to three times, daily.

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)

Description

Die vorliegende Erfindung betrifft neue substituierte Aminoalkanolphospholipide und Verfahren zu ihrer Herstellung.The present invention relates to new substituted aminoalkanol phospholipids and processes for their preparation.

Die erfindungsgemässen Verbindungen entsprechen der allgemeinen Formel

Figure imgb0001
worin X ein Sauerstoff- oder Schwefelatom und Y den Rest-NR1R2 oder-OR3 bedeuten, wobei R1, R2 gleich oder voneinander verschieden sein können und einen gesättigten oder ungesättigten, geradkettigen oder verzweigten Alkylrest mit 1-20 Kohlenstoffatomen, einen Benzylrest, Phenylrest oder Wasserstoff darstellen, und R3 für Phenyl, Benzyl oder C1-4-Alkyl steht. R4, R5, R6 können gleich oder voneinander verschieden sein und stehen für Wasserstoff oder einen niederen Alkylrest mit 1-4 Kohlenstoffatomen. 1 bedeutet eine ganze Zahl von 0-19, m eine ganze Zahl von 2-6, n eine ganze Zahl von 2-4.The compounds according to the invention correspond to the general formula
Figure imgb0001
in which X is an oxygen or sulfur atom and Y is the radical NR 1 R 2 or -OR 3 , where R 1 , R 2 can be identical or different and a saturated or unsaturated, straight-chain or branched alkyl radical having 1-20 carbon atoms, represent a benzyl radical, phenyl radical or hydrogen, and R 3 represents phenyl, benzyl or C 1-4 alkyl. R 4 , R 5 , R 6 can be the same or different and stand for hydrogen or a lower alkyl radical with 1-4 carbon atoms. 1 means an integer from 0-19, m an integer from 2-6, n an integer from 2-4.

Verbindungen gemäss der Erfindung sind beispielsweise:

  • 2-(3-Hexadecyl-1-methylureido)-ethanol-phosphocholin
  • 2-(1-Methyl-3-octadecylureido)-ethanol-phosphocholin
  • 2-(3-Eicosyl-1-methylureido)-ethanol-phosphocholin
  • 2-(1-Methyl-3-oleylureido)-ethanol-phosphocholin
  • 2-(3-Methyl-1-undecylureido)-ethanol-phosphocholin
  • 2-(3-Ethyl-1-undecylureido)-ethanol-phosphocholin
  • 2-(3,3-Dimethyl-1-undecylureido)-ethanol-phosphocholin
  • 2-(3-Methyl-1-undecylthioureido)-ethanol-phosphocholin
  • 2-(1-Hexadecyl-3-methylureido)-ethanol-phosphocholin
  • 2-(3-Ethyl-1-hexadecylureido)-ethanol-phosphocholin
  • 2-(1-Hexadecyl-3-methylthioureido)-ethanol-phosphocholin
  • 2-(3,3-Dimethyl-1-hexadecylureido)-ethanol-phosphocholin
  • 2-(3-Methyl-1-octadecylureido)-ethanol-phosphocholin
  • 2-(3-Ethyl-1-octadecylureido)-ethanol-phosphocholin
  • 2-(3,3-Dimethyl-1-octadecylureido)-ethanol-phosphocholin
  • 2-(3-Methyl-1-octadecylthioureido)-ethanol-phosphocholin
  • 2-(3-Butyl-1-octadecylureido)-ethanol-phosphocholin
  • 2-(3-Hexadecyl-1-octadecylureido)-ethanol-phosphocholin
  • 2-(3-Benzyl-1-octadecylureido)-ethanol-phosphocholin
  • 3-(3-Methyl-1-octadecylureido)-propanol-(1 )-phosphocholin
  • 3-(3-Ethyl-1-octadecylureido)-propanol-(1 )-phosphocholin
  • 3-(3,3-Dimethyl-1-octadecylureido)-propanol-(1 )-phosphocholin
  • 3-(3-Methyl-1-octadecylthioureido)-propanol-(1 )-phosphochloin
  • 4-(3-Methyl-1-octadecylureido)-butanol-(1 )-phosphocholin
  • 4-(3-Ethyl-1-octadecylureido)-butanol-(1 )-phosphocholin
  • 4-(3,3-Dimethyl-1-octadecylureido)-butanol-(1 )-phosphocholin
  • 4-(3-Methyl-1-octadecylthioureido)-butanol-(1 )-phosphocholin
  • 2-(1-Eicosyl-3-methylureido)-ethanol-phosphocholin
  • 2-(1-Eicosyl-3-ethylureido)-ethanol-phosphocholin
  • 2-(3,3-Dimethyl-1-eicosylureido)-ethanol-phosphocholin
  • 2-(1-Eicosyl-3-methylthioureido)-ethanol-phosphocholin
  • 2-(3-Phenyl-1-undecylureido)-ethanol-phosphocholin
  • 2-(3-Benzyl-1-undecylureido)-ethanol-phosphocholin
  • 2-(1-Undecylureido)-ethanol-phosphocholin 2-(3-Hexadecyl-1-undecylureido)-ethanol-phosphocholin
  • 2-(3-Oleyl-1-undecylureido)-ethanol-phosphocholin
  • (2-(3-Methyl-1-octadecylureido)-ethyl]-(2-tri- ethylammonioethyl)-phosphat
  • [2-(3-Methyl-1-octadecylureido)-ethyl]-(2-di- methylammonioethyl)-phosphat
  • N-Benzyloxycarbonyl-N-methyl-2-aminoethanol-(1 )-phosphocholin
  • N-Benzyloxycarbonyl-N-undecyl-2-aminoethanol-(1 )-phosphocholin
  • N-Benzyloxycarbonyl-N-hexadecyl-2-aminoethanol-(1 )-phosphocholin
  • N-Benzyloxycarbonyl-N-octadecyl-2-aminoethanol-(1 )-phosphocholin
  • N-Benzylocycarbonyl-N-octadecyl-3-aminopro- panol-(1 )-phosphocholin
  • N-Benzyloxycarbonyl-N-Octadecyl-4-aminobutanol-(1 )-phosphocholin
  • N-Benzyloxycarbonyl-N-eicosyl-2-aminoethanol-(1 )-phosphocholin
  • N-Methoxycarbonyl-N-octadecyl-2-aminoethanol-(1 )-phosphocholin
  • N-Ethoxycarbonyl-N-octadecyl-2-aminoethanol-(1 )-phosphocholin.
Compounds according to the invention are, for example:
  • 2- (3-hexadecyl-1-methylureido) ethanol phosphocholine
  • 2- (1-methyl-3-octadecylureido) ethanol phosphocholine
  • 2- (3-eicosyl-1-methylureido) ethanol phosphocholine
  • 2- (1-methyl-3-oleylureido) ethanol phosphocholine
  • 2- (3-methyl-1-undecylureido) ethanol phosphocholine
  • 2- (3-ethyl-1-undecylureido) ethanol phosphocholine
  • 2- (3,3-Dimethyl-1-undecylureido) ethanol phosphocholine
  • 2- (3-methyl-1-undecylthioureido) ethanol phosphocholine
  • 2- (1-Hexadecyl-3-methylureido) ethanol phosphocholine
  • 2- (3-ethyl-1-hexadecylureido) ethanol phosphocholine
  • 2- (1-Hexadecyl-3-methylthioureido) ethanol phosphocholine
  • 2- (3,3-Dimethyl-1-hexadecylureido) ethanol phosphocholine
  • 2- (3-methyl-1-octadecylureido) ethanol phosphocholine
  • 2- (3-ethyl-1-octadecylureido) ethanol phosphocholine
  • 2- (3,3-Dimethyl-1-octadecylureido) ethanol phosphocholine
  • 2- (3-methyl-1-octadecylthioureido) ethanol phosphocholine
  • 2- (3-butyl-1-octadecylureido) ethanol phosphocholine
  • 2- (3-Hexadecyl-1-octadecylureido) ethanol phosphocholine
  • 2- (3-benzyl-1-octadecylureido) ethanol phosphocholine
  • 3- (3-methyl-1-octadecylureido) propanol (1) phosphocholine
  • 3- (3-ethyl-1-octadecylureido) propanol (1) phosphocholine
  • 3- (3,3-Dimethyl-1-octadecylureido) propanol (1) phosphocholine
  • 3- (3-methyl-1-octadecylthioureido) propanol (1) phosphochloin
  • 4- (3-methyl-1-octadecylureido) butanol (1) phosphocholine
  • 4- (3-ethyl-1-octadecylureido) butanol (1) phosphocholine
  • 4- (3,3-dimethyl-1-octadecylureido) butanol (1) phosphocholine
  • 4- (3-methyl-1-octadecylthioureido) butanol (1) phosphocholine
  • 2- (1-eicosyl-3-methylureido) ethanol phosphocholine
  • 2- (1-eicosyl-3-ethylureido) ethanol phosphocholine
  • 2- (3,3-Dimethyl-1-eicosylureido) ethanol phosphocholine
  • 2- (1-eicosyl-3-methylthioureido) ethanol phosphocholine
  • 2- (3-phenyl-1-undecylureido) ethanol phosphocholine
  • 2- (3-benzyl-1-undecylureido) ethanol phosphocholine
  • 2- (1-Undecylureido) ethanol phosphocholine 2- (3-Hexadecyl-1-undecylureido) ethanol phosphocholine
  • 2- (3-oleyl-1-undecylureido) ethanol phosphocholine
  • (2- (3-methyl-1-octadecylureido) ethyl] - (2-triethylammonioethyl) phosphate
  • [2- (3-methyl-1-octadecylureido) ethyl] - (2-dimethylammonioethyl) phosphate
  • N-benzyloxycarbonyl-N-methyl-2-aminoethanol (1) phosphocholine
  • N-benzyloxycarbonyl-N-undecyl-2-aminoethanol- (1) -phosphocholine
  • N-benzyloxycarbonyl-N-hexadecyl-2-aminoethanol- (1) -phosphocholine
  • N-benzyloxycarbonyl-N-octadecyl-2-aminoethanol (1) phosphocholine
  • N-Benzylocycarbonyl-N-octadecyl-3-aminopropanol (1) phosphocholine
  • N-benzyloxycarbonyl-N-octadecyl-4-aminobutanol (1) phosphocholine
  • N-benzyloxycarbonyl-N-eicosyl-2-aminoethanol (1) phosphocholine
  • N-methoxycarbonyl-N-octadecyl-2-aminoethanol (1) phosphocholine
  • N-ethoxycarbonyl-N-octadecyl-2-aminoethanol (1) phosphocholine.

Die erfindungsgemässen Verbindungen sind biologisch sehr aktiv und können z.B. in Arzneimitteln und im Pflanzenschutz eingesetzt werden. Die neuen Verbindungen zeigen eine starke pharmakologische Wirkung, insbesondere zeigen sie eine blutdrucksenkende und immunregulative Wirkung. Sie können daher zur Behandlung des Hochdrucks, aber auch zur Behandlung entzündlicher Krankheiten und zur Therapie der Atherosklerose sowie von Tumoren genutzt werden. Bei den strukturähnlichen Verbindungen der JP-A-55118494 und JP-A-56 115 792 wurde nur r eine Antitumor-Wirkung festgestellt.The compounds according to the invention are very biologically active and can be used, for example, in pharmaceuticals and in crop protection the. The new compounds show a strong pharmacological effect, in particular they have a hypotensive and immunoregulatory effect. They can therefore be used to treat high pressure, but also to treat inflammatory diseases and to treat atherosclerosis and tumors. In the structure-like compounds of JP-A-55118494 and JP-A-56 115 792, only an antitumor effect was found.

Zur Herstellung der neuen Ureidoalkylphospholipide werden N-Alkyl-aminoalkanole der allgemeinen Formel ll

Figure imgb0002
worin und m die in Formel angegebene Bedeutung besitzen, in einem indifferenten organischen Lösungsmittel, wie z.B. Ether, Tetrahydrofuran, Dioxan, Aceton, Chloroform, Dimethylformamid mit einem Benzylhalogenid oder Chlorameisensäurebenzylester, bevorzugt in Gegenwart einer Hilfsbase, wie z.B. Pyridin, Dimethylaminopyridin, Triethylamin, Alkalihydroxid, Erdalkalioxid, zu den Verbindungen der allgemeinen Formel lll umgesetzt.To produce the new ureidoalkylphospholipids, N-alkylaminoalkanols of the general formula II
Figure imgb0002
in which and m have the meaning given in the formula, in an inert organic solvent such as ether, tetrahydrofuran, dioxane, acetone, chloroform, dimethylformamide with a benzyl halide or benzyl chloroformate, preferably in the presence of an auxiliary base such as pyridine, dimethylaminopyridine, triethylamine, alkali metal hydroxide , Alkaline earth oxide, converted to the compounds of general formula III.

Die Reaktion kann auch zweiphasig, ggfs unter Anwendung eines Phasen-Transferkatalysators durchgeführt werden. Die Verbindungen lll mit R7 = Benzyl und m = 2 können auch aus N-Benzylalkylaminen und Ethylenoxid hergestellt werden. Die Verbindungen ll sind entweder durch Umsetzung der entsprechenden Amine mit Ethylenoxid oder durch Reduktion von N-Acyl-ω-aminoalkanolen zugänglich.The reaction can also be carried out in two phases, if necessary using a phase transfer catalyst. The compounds III with R 7 = benzyl and m = 2 can also be prepared from N-benzylalkylamines and ethylene oxide. The compounds II are accessible either by reacting the corresponding amines with ethylene oxide or by reducing N-acyl-ω-aminoalkanols.

Die Verbindungen der allgemeinen Formel lll

Figure imgb0003
worin I und m die in Formel l angegebenen Bedeutungen besitzen und R7 einen durch Hydrierung abspaltbaren Rest, wie z.B. Benzyl oder Benzyloxycarbonyl darstellt, werden nach an sich bekannten Verfahren in die Phospholipide der allgemeinen Formel IV
Figure imgb0004
worin R4, R5, R6, 1, m und n die in Formel 1 und R7 die in Formel lll angegebene Bedeutung besitzen, überführt. Verbindungen der Formel IV mit R7 = Benzyloxycarbonyl entsprechen Verbindungen der Formel 1 mit R3 = Benzyl.The compounds of the general formula III
Figure imgb0003
wherein I and m have the meanings given in formula I and R 7 is a radical which can be split off by hydrogenation, such as, for example, benzyl or benzyloxycarbonyl, are converted into the phospholipids of the general formula IV by processes known per se
Figure imgb0004
wherein R4, R5, R6, 1, m and n have the meaning given in formula 1 and R 7 as defined in formula III. Compounds of formula IV with R 7 = benzyloxycarbonyl correspond to compounds of formula 1 with R 3 = benzyl.

Beispielsweise lassen sich die Verbindungen lll mit Dichlorphosphorsäure-cu-halogenalkylestern der Formel V

Figure imgb0005
worin n die in Formel I angegebene Bedeutung hat und Hal ein Chlor- oder Bromatom ist, in einem indifferenten organischen Lösungsmittel, ggfs unter Anwendung einer Hilfsbase, phosphorylieren und nachfolgend durch Reaktion mit einem Amin der Formel VI
Figure imgb0006
worin R4, R5, R6 die in Formel angegebenen Bedeutungen besitzen, in einem indifferenten organischen Lösungsmittel, ggfs unter Druck, zu den Verbindungen der Formel IV umsetzen [H.K. Mangold, Angew. Chem. 91, 550-560 (1979); H. Eibl, Chem. and Phys. of Lipids 26, 405-429, (1980)].For example, the compounds III with dichlorophosphoric acid-cu-haloalkyl esters of the formula V
Figure imgb0005
wherein n has the meaning given in formula I and Hal is a chlorine or bromine atom, phosphorylate in an inert organic solvent, if appropriate using an auxiliary base, and subsequently by reaction with an amine of the formula VI
Figure imgb0006
in which R4, R5, R6 have the meanings given in the formula, in an inert organic solvent, if appropriate under pressure, to give the compounds of the formula IV [HK Mangold, Angew. Chem. 91, 550-560 (1979); H. Eibl, Chem. And Phys. of Lipids 26, 405-429, (1980)].

Die Verbindungen der Formal IV können auch hergestellt werden, indem man Verbindungen der Formel lll mit Phosphoroxytrichlorid und nachfolgend mit einem Alkandiol der Formel VII HO-(CH2)n-OH Vll in der n die in Formel I angegebene Bedeutung besitzt, ggfs unter Einsatz von Hilfsbasen, wie z.B. Triethylamin, und Anwendung inerter Lösungsmittel, wie z.B. Tetrahydrofuran, zu cyclischen Zwischenprodukten der Formel VIII

Figure imgb0007
worin I, m, n und R7 die in Formel IV angegebenen Bedeutungen besitzen, umsetzt [H. Eibl, Phospholipid Synthesis in Knight (Herausgeber), Liposomes, Elsevier 1981, S. 19-50].The compounds of the formal IV can also be prepared by using compounds of the formula III with phosphorus oxytrichloride and subsequently with an alkanediol of the formula VII HO- (CH 2 ) n -OH VII in which n has the meaning given in formula I, if appropriate using from auxiliary bases, such as triethylamine, and use of inert solvents, such as tetrahydrofuran, to give cyclic intermediates of the formula VIII
Figure imgb0007
wherein I, m, n and R 7 have the meanings given in formula IV, implemented [H. Eibl, Phospholipid Synthesis in Knight (Editor), Liposomes, Elsevier 1981, pp. 19-50].

Die Zwischenprodukte der Formel VIII lassen sich auch darstellen, indem man Verbindungen der Formel lll mit einer cyclischen Phosphorverbindung der Formal IX

Figure imgb0008
worin n die in Formel I angegebene Bedeutung hat, in einem indifferenten organischen Lösungsmittel unter Zusatz einer Hilfsbase umsetzt [N.S. Chandrakumar et al., Tetrahedron Lett. 23, 1043-46, (1982); Biochim. Biophys. Acta 711, 357-360, (1982)].The intermediates of formula VIII can also be prepared by compounds of formula III with a cyclic phosphorus compound of formal IX
Figure imgb0008
where n has the meaning given in formula I, in an inert organic solvent with the addition of an auxiliary base [NS Chandrakumar et al., Tetrahedron Lett. 23, 1043-46, (1982); Biochim. Biophys. Acta 711, 357-360, (1982)].

Die Zwischenprodukte Vlll lassen sich auf einfache Weise, z.B. durch Behandlung mit einem Amin der Formel VI in einem organischen Lösungsmittel, ggfs unter Druck, in die Verbindungen der Formel IV überführen (N.T. Thuong und P. Chabrier, Bull. Soc. Chim. Fr. 1974,667-671).The intermediates VIII can be easily introduced into the compound, for example by treatment with an amine of the formula VI in an organic solvent, if appropriate under pressure gen IV formula (NT Thuong and P. Chabrier, Bull. Soc. Chim. Fr. 1974,667-671).

Die Verbindungen der allgemeinen Formel IV werden in einem geeigneten organischen Lösungsmittel, wie z.B. Methanol, Ethanol, Ether, Dioxan oder deren Mischungen untereinander und mit Wasser unter Abspaltung der Benzylgruppe in Gegenwart eines üblichen Hydrierkatalysators, wie z.B. Palladium/Aktivkohle, mit Wasserstoff hydriert, wobei die Verbindungen der allgemeinen Formel X

Figure imgb0009
worin R4, R5, R6, 1, m und n die in Formel l angegebenen Bedeutungen besitzen, entstehen.The compounds of general formula IV are hydrogenated with hydrogen in a suitable organic solvent, such as, for example, methanol, ethanol, ether, dioxane or mixtures thereof with one another and with water, with the benzyl group being split off, in the presence of a customary hydrogenation catalyst, such as, for example, palladium / activated carbon the compounds of the general formula X
Figure imgb0009
wherein R 4 , R 5 , R 6 , 1, m and n have the meanings given in formula I, arise.

Die Verbindungen der Formel X werden mit Kohlensäurederivaten der Formal XI oder Xll

Figure imgb0010
Figure imgb0011
worin R1, R2 und X die in Formal I angegebenen Bedeutungen haben, in Substanz oder in einem indifferenten organischen Lösungsmittel, wie z.B. Dimethylformamid, Chloroform, N-Methylacetamid, ggfs unter Zusatz eines Katalysators, wie z.B. Dimethylaminopyridin oder einer Base, wie z.B. Pyridin, Triethylamin, insbesondere bei Verwendung von Verbindungen der Formal XII, zu den erfindungsgemässen Verbindungen der Formel umgesetzt.The compounds of formula X are with carbonic acid derivatives of the formal XI or Xll
Figure imgb0010
Figure imgb0011
wherein R 1 , R 2 and X have the meanings given in formal I, in bulk or in an inert organic solvent, such as dimethylformamide, chloroform, N-methylacetamide, optionally with the addition of a catalyst, such as dimethylaminopyridine or a base, such as Pyridine, triethylamine, in particular when using compounds of the formal XII, converted to the compounds of the formula according to the invention.

Die Verbindungen der Formel mit R1 = R2 = H lassen sich zweckmässig in wässrigen oder wässrig-organischen Medien, wie z.B. Wasser/Dioxan, unter Verwendung von Alkalicyanaten, ggfs unter Zusatz einer organischen oder anorganischen Säure, vorzugsweise Essigsäure, analog den bekannten Harnstoffsynthesen (vergl. z.B. Weygand-Hilgetag, Org. Chem. Experimentierkunst, Verlag J.A. Barth-Leipzig 1970, S. 420) aus den Verbindungen der Formel X herstellen.The compounds of the formula where R 1 = R 2 = H can expediently be used in aqueous or aqueous-organic media, such as, for example, water / dioxane, using alkali metal cyanates, if appropriate with the addition of an organic or inorganic acid, preferably acetic acid, analogously to the known urea syntheses (see, for example, Weygand-Hilgetag, Org. Chem. Experimentierkunst, Verlag JA Barth-Leipzig 1970, p. 420) from the compounds of formula X.

Auch können die Verbindungen der Formel I mit R1 = Benzyl und R2 = H sowie X = 0 in einem geeigneten organischen Lösungsmittel, wie z.B. Methanol, Ethanol, Ether, Dioxan oder deren Mischungen untereinander und mit Wasser unter Abspaltung der Benzylgruppe in Gegenwart eines üblichen Hydrierkatalysators, wie z.B. Palladium/Aktivkohle, mit Wasserstoff hydriert werden, wobei Verbindungen der Formel l mit R1 = R2 = H entstehen.The compounds of formula I with R 1 = benzyl and R 2 = H and X = 0 in a suitable organic solvent, such as methanol, ethanol, ether, dioxane or mixtures thereof with one another and with water with elimination of the benzyl group in the presence of a Conventional hydrogenation catalyst, such as palladium / activated carbon, are hydrogenated with hydrogen, compounds of the formula I with R 1 = R 2 = H being formed.

Zur Herstellung der neuen (Aryl)alkyloxycarbo- nylaminoalkanolphospholipide der Formel I werden N-Alkyl-aminoalkohole der Formel ll in einem indifferenten organischen Lösungsmittel, wie z.B. Ether, Tetrahydrofuran, Dioxan, Aceton, Chloroform, Dimethylformamid mit Chlorameisensäurebenzylester, Chlorameisensäurephenylester oder Chlorameisensäurealkylestern, bevorzugt in Gegenwart einer Hilfsbase, wie z.B. Pyridin, Dimethylaminopyridin, Triethylamin, Alkalihydroxid, Erdalkalioxid, zu den Verbindungen der allgemeinen Formel XIII umgesetzt.To prepare the new (aryl) alkyloxycarbonylaminoalkanol phospholipids of the formula I, N-alkylamino alcohols of the formula II are used in an inert organic solvent, such as e.g. Ether, tetrahydrofuran, dioxane, acetone, chloroform, dimethylformamide with benzyl chloroformate, phenyl chloroformate or alkyl chloroformate, preferably in the presence of an auxiliary base, such as e.g. Pyridine, dimethylaminopyridine, triethylamine, alkali metal hydroxide, alkaline earth metal oxide, converted to the compounds of the general formula XIII.

Figure imgb0012
Figure imgb0012

Die Verbindungen der Formel XIII, worin R3, I und m die in Formel angegebenen Bedeutungen besitzen, werden nach an sich bekannten Verfahren in die Phospholipide der allgemeinen Formel überführt.The compounds of the formula XIII, in which R 3 , I and m have the meanings given in the formula, are converted into the phospholipids of the general formula by processes known per se.

Beispielsweise lassen sich die Verbindungen der Formel Xlll mit Dichlorphosphorsäure-ca-halogen-alkylestern der Formel V in einem indifferenten organischen Lösungsmittel, ggfs unter Anwendung einer Hilfsbase, phosphorylieren und nachfolgend durch Reaktion mit einem Amin der Formel VI in einem indifferenten organischen Lösungsmittel, ggfs unter Druck, zu den Verbindungen der Formel 1 umsetzen.For example, the compounds of the formula XIII can be phosphorylated with dichlorophosphoric acid ca-halogenoalkyl esters of the formula V in an inert organic solvent, if appropriate using an auxiliary base, and subsequently by reaction with an amine of the formula VI in an inert organic solvent, if appropriate Pressure to convert to the compounds of Formula 1.

Die Verbindungen der Formel I können auch hergestellt werden, indem man Verbindungen der Formel Xlll mit Phosphoroxytrichlorid phosphoryliert und nachfolgend mit einem Alkandiol der Formel VII oder mit Verbindungen der Formel IX ggfs, unter Einsatz von Hilfsbasen wie z.B. Triethylamin und Verwendung inerter Lösungsmittel wie z.B. Tetrahydrofuran zu den cyclischen Zwischenprodukten der Formel XIV

Figure imgb0013
worin 1, m, n und R3 die in Formel angegebenen Bedeutungen besitzen, umsetzt.The compounds of the formula I can also be prepared by phosphorylating compounds of the formula III with phosphorus oxytrichloride and subsequently with an alkanediol of the formula VII or with compounds of the formula IX, if appropriate, using auxiliary bases such as triethylamine and using inert solvents such as tetrahydrofuran the cyclic intermediates of formula XIV
Figure imgb0013
wherein 1, m, n and R 3 have the meanings given in the formula.

Die Zwischenprodukte XIV lassen sich auf einfache Weise, z.B. durch Behandlung mit einem Amin der Formel VI, in einem organischen Lösungsmittel, ggfs unter Druck, in die Verbindungen der Formel I überführen. Die Verbindungen der Formel 1 lassen sich auch darstellen, indem man Verbindungen der Formel X mit Chlorameisensäureestern in inerten Lösungsmitteln, wie z.B. Chloroform, Dimethylformamid, ggfs unter Zusatz einer Hilfsbase, wie z.B. Pyridin, Triethylamin, umsetzt.The intermediate products XIV can be easily, e.g. by treatment with an amine of the formula VI, in an organic solvent, if appropriate under pressure, into the compounds of the formula I. The compounds of formula 1 can also be prepared by reacting compounds of formula X with chloroformic acid esters in inert solvents, such as e.g. Chloroform, dimethylformamide, if necessary with the addition of an auxiliary base, e.g. Pyridine, triethylamine.

Als Ausgangsverbindungen der Formel kommen z.B. folgende Verbindungen in Frage:

  • 2-Methylamino-ethanol, 2-Ethylamino-ethanol,
  • 2-Propylamino-ethanol, 2-Butylamino-ethanol,
  • 2-Pentylamino-ethanol, 2-Hexylamino-ethanol,
  • 2-Heptylamino-ethanol, 2-Octylamino-ethanol,
  • 2-Nonylamino-ethanol, 2-Decylamino-ethanol,
  • 2-Undecylamino-ethanol, 2-Dodecylamino-ethanol,
  • 2-Tridecylamino-ethanol, 2-Tetradecylaminoethanol,
  • 2-Pentadecylamino-ethanol, 2-Hexadecylamino-ethanol,
  • 2-Heptadecylamino-ethanol, 2-Octadecylamino-ethanol,
  • 2-Nonadecylamino-ethanol,2-Eicosylamino-ethanol,
  • 3-Methylamino-propanol, 3-Ethylamino-propanol,
  • 3-Propylamino-propanol, 3-Butylamino-propanol,
  • 3-Pentylamino-propanol, 3-Hexylamino-propanol,
  • 3-Heptylamino-propanol, 3-Octylamino-propanol,
  • 3-Nonylamino-propanol, 3-Decylamino-propanol,
  • 3-Undecylamino-propanol, 3-Dodecylamino-propanol,
  • 3-Tridecylamino-propanol, 3-Tetradecylaminopropanol,
  • 3-Pentadecylamino-propanol, 3-Hexadecylamino-propanol,
  • 3-Heptadecylamino-propanol, 3-Octadecylamino-propanol,
  • 3-Nonadecylamino-propanol,
  • 3-Eicosylamino-propanol, 4-Methylamino-butanol,
  • 4-Ethylamino-butanol,4-Propylamino-butanol,
  • 4-Butylamino-butanol,4-Pentylamino-butanol,
  • 4-Hexylamino-butanol, 4-Heptylamino-butanol,
  • 4-Octylamino-butanol, 4-Nonylamino-butanol,
  • 4-Decylamino-butanol,4-Undecylamino-butanol,
  • 4-Dodecylamino-butanol, 4-Tridecylamino-butanol,
  • 4-Tetradecylamino-butanol, 4-Pentadecylamino-butanol,
  • 4-Hexadecylamino-butanol,4-Heptadecylamino-butanol,
  • 4-Nonadecylamino-butanol, 4-Octadecylamino-butanol,
  • 4-Eicosylamino-butanol, 5-Methylamino-pentanol,
  • 5-Ethylamino-pentanol, 5-Propylamino-pentanol,
  • 5-Butylamino-pentanol, 5-Pentylamino-pentanol,
  • 5-Hexylamino-pentanol, 5-Heptylamino-pentanol,
  • 5-Octylamino-pentanol, 5-Nonylamonio-pentanol,
  • 5-Decylamino-pentanol, 5-Undecylamino-pentanol,
  • 5-Dodecylamino-pentanol, 5-Tridecylamino-pentanol,
  • 5-Tetradecylamino-pentanol, 5-Pentadecylamino-pentanol,
  • 5-Hexadecylamino-pentanol, 5-Heptadecylamino-pentanol,
  • 5-Octadecylamino-pentanol, 5-Nonadecylamino-pentanol,
  • 5-Eicosylamino-pentanol, 6-Methylamino-hexanol,
  • 6-Ethylamino-hexanol, 6-Propylamino-hexanol,
  • 6-Butylamino-hexanol, 6-Pentylamino-hexanol,
  • 6-Hexylamino-hexanol, 6-Heptylamino-hexanol,
  • 6-Octylamino-hexanol, 6-Nonylamino-hexanol,
  • 6-Decylamino-hexanol, 6-Undecylamino-hexanol,
  • 6-Dodecylamino-hexanol, 6-Tridecylamino-hexanol,
  • 6-Tetradecylamino-hexanol, 6-Pentadecylamino-hexanol,
  • 6-Octadecylamino-hexanol, 6-Hexadecylaminohexanol,
  • 6-Heptadecylamino-hexanol, 6-Nonadecylamino-hexanol oder
  • 6-Eicosylamino-hexanol
The following compounds are suitable as starting compounds of the formula:
  • 2-methylaminoethanol, 2-ethylaminoethanol,
  • 2-propylaminoethanol, 2-butylaminoethanol,
  • 2-pentylaminoethanol, 2-hexylaminoethanol,
  • 2-heptylamino-ethanol, 2-octylamino-ethanol,
  • 2-nonylaminoethanol, 2-decylaminoethanol,
  • 2-undecylamino-ethanol, 2-dodecylamino-ethanol,
  • 2-tridecylaminoethanol, 2-tetradecylaminoethanol,
  • 2-pentadecylaminoethanol, 2-hexadecylaminoethanol,
  • 2-heptadecylamino-ethanol, 2-octadecylamino-ethanol,
  • 2-nonadecylaminoethanol, 2-eicosylaminoethanol,
  • 3-methylamino propanol, 3-ethylamino propanol,
  • 3-propylamino propanol, 3-butylamino propanol,
  • 3-pentylamino propanol, 3-hexylamino propanol,
  • 3-heptylamino propanol, 3-octylamino propanol,
  • 3-nonylamino propanol, 3-decylamino propanol,
  • 3-undecylamino propanol, 3-dodecylamino propanol,
  • 3-tridecylamino-propanol, 3-tetradecylaminopropanol,
  • 3-pentadecylamino propanol, 3-hexadecylamino propanol,
  • 3-heptadecylamino propanol, 3-octadecylamino propanol,
  • 3-nonadecylamino propanol,
  • 3-eicosylamino-propanol, 4-methylamino-butanol,
  • 4-ethylamino-butanol, 4-propylamino-butanol,
  • 4-butylamino-butanol, 4-pentylamino-butanol,
  • 4-hexylamino-butanol, 4-heptylamino-butanol,
  • 4-octylamino-butanol, 4-nonylamino-butanol,
  • 4-decylamino-butanol, 4-undecylamino-butanol,
  • 4-dodecylamino-butanol, 4-tridecylamino-butanol,
  • 4-tetradecylamino-butanol, 4-pentadecylamino-butanol,
  • 4-hexadecylamino-butanol, 4-heptadecylamino-butanol,
  • 4-nonadecylamino-butanol, 4-octadecylamino-butanol,
  • 4-eicosylamino-butanol, 5-methylamino-pentanol,
  • 5-ethylamino-pentanol, 5-propylamino-pentanol,
  • 5-butylamino-pentanol, 5-pentylamino-pentanol,
  • 5-hexylamino-pentanol, 5-heptylamino-pentanol,
  • 5-octylamino-pentanol, 5-nonylamino-pentanol,
  • 5-decylamino-pentanol, 5-undecylamino-pentanol,
  • 5-dodecylamino-pentanol, 5-tridecylamino-pentanol,
  • 5-tetradecylamino-pentanol, 5-pentadecylamino-pentanol,
  • 5-hexadecylamino-pentanol, 5-heptadecylamino-pentanol,
  • 5-octadecylamino-pentanol, 5-nonadecylamino-pentanol,
  • 5-eicosylamino-pentanol, 6-methylamino-hexanol,
  • 6-ethylamino-hexanol, 6-propylamino-hexanol,
  • 6-butylamino-hexanol, 6-pentylamino-hexanol,
  • 6-hexylamino-hexanol, 6-heptylamino-hexanol,
  • 6-octylamino-hexanol, 6-nonylamino-hexanol,
  • 6-decylamino-hexanol, 6-undecylamino-hexanol,
  • 6-dodecylamino-hexanol, 6-tridecylamino-hexanol,
  • 6-tetradecylamino-hexanol, 6-pentadecylamino-hexanol,
  • 6-octadecylamino-hexanol, 6-hexadecylaminohexanol,
  • 6-heptadecylamino-hexanol, 6-nonadecylamino-hexanol or
  • 6-eicosylamino-hexanol

Als Ausgangsverbindungen der Formel V kommen z.B. in Frage: Dichlorphosphorsäure-2-brom- ethylester, Dichlorphosphorsäure-2-chlorethyl- ester, Dichlorphosphorsäure-3-brompropylester, Dichlorphosphorsäure-4-brombutylester.The starting compounds of formula V are e.g. in question: dichlorophosphoric acid 2-bromo-ethyl ester, dichlorophosphoric acid 2-chloroethyl ester, dichlorophosphoric acid 3-bromopropyl ester, dichlorophosphoric acid 4-bromobutyl ester.

Als Ausgangsverbindungen der Formel VI kommen bevorzugt sekundäre und tertiäre Amine in Frage z.B.:

  • Dimethylamin, Diethylamin, Dipropylamin, Dibutylamin, Trimethylamin, Triethylamin, Tripropylamin, Tributylamin, Ethylmethylamin, Methylpropylamin, Ethylpropylamin, Butylmethylamin, Butylethylamin,Butylpropylamin,Dimethylethylamin, Butyldimethylamin, Diethylmethylamin, Diethylpropylamin,Butyldiethylamin,Dipro- pylmethylamin,Dipropylethylamin,Butyldipropyl- amin, Dibutylmethylamin, Dibutylethylamin, Dibutylpropylamin, Ethylmethylpropylamin, Butylmethylpropylamin, Butylethylmethylamin, Butylethylpropylamin.
Preferred starting compounds of the formula VI are secondary and tertiary amines, for example:
  • Dimethylamine, diethylamine, dipropylamine, dibutylamine, trimethylamine, triethylamine, tripropylamine, tributylamine, ethylmethylamine, methylpropylamine, ethylpropylamine, butylmethylamine, butylethylamine, butylpropylamine, dimethylethylamine, butyldimethylamine, diethylmethylamine, dipylopropylmethylamine, dietylpropylmethylamine, dipylpropylmethylamine, dietylpropylmethylamine, dietylpropylmethylamine, Dibutylethylamine, dibutylpropylamine, ethylmethylpropylamine, butylmethylpropylamine, butylethylmethylamine, butylethylpropylamine.

Als Ausgangsverbindungen der Formel XI kommen z.B. in Frage:

  • Methylisocyanat, Methylisothiocyanat, Ethylisocyanat, Ethylisothiocyanat, Propylisocyanat, Propylisothiocyanat, Isopropylisocyanat, Isopropylisothiocyanat, Butylisocyanat, Butylisothiocyanat, Allylisocyanat, Allylisothiocyanat, Hexylisocyanat, Hexylisothiocyanat, Octiylisocyanat, Octylisothiocyanat, Decylisocyanat, Decylisothiocyanat, Undecylisocyanat, Undecylisothiocyanat, Dodecylisocyanat, Dodecylisothiocyanat, Tetradecylisocyanat, Tetradecylisothiocyanat, Hexadecylisocyanat, Hexadecylisothiocyanat, Octadecylisocyanat, Octadecylisothiocyanat, Oleylisocyanat, Oleylisothiocyanat, Eicosylisocyanat, Eicosylisothiocyanat, Phenylisocyanat, Benzylisocyanat, Phenylisothiocyanat, Benzylisothiocyanat.
Examples of possible starting compounds of the formula XI are:
  • Methyl isocyanate, methyl isothiocyanate, ethyl isocyanate, ethyl isothiocyanate, propyl isocyanate, propyl isothiocyanate, isopropyl isocyanate, isopropyl isothiocyanate, butyl isocyanate, butyl isothiocyanate, allyl isocyanate, allyl isothiocyanate, hexyl isocyanate, Hexylisothiocyanat, Octiylisocyanat, Octylisothiocyanat, Decylisocyanat, Decylisothiocyanat, Undecylisocyanat, Undecylisothiocyanat, dodecyl, Dodecylisothiocyanat, tetradecyl isocyanate, Tetradecylisothiocyanat, hexadecyl, Hexadecyl isothiocyanate, octadecyl isocyanate, octadecyl isothiocyanate, oleyl isocyanate, oleyl isothiocyanate, eicosyl isocyanate, eicosyl isothiocyanate, phenyl isocyanate, benzyl isocyanate, phenyl isothiocyanate, benzyl isothiocyanate.

Als Ausgangsverbindungen der Formel XII kommen bevorzugt Carbamidsäure- und Thiocarbamidsäurechloride in Frage, deren Substituenten R1, R2 eine kurzkettige Kohlenwasserstoffkette mit 1-4 C-Atomen enthalten, z.B.:

  • Dimethylcarbamidsäurechlorid,
  • Diethylcarbamidsäurechlorid
  • Dipropylcarbamidsäurechlorid,
  • Dibutylcarbamidsäurechlorid,
  • Methylethylcarbamidsäurechlorid,
  • Methylpropylcarbamidsäurechlorid,
  • Methylbutylcarbamidsäurechlorid,
  • Ethylpropylcarbamidsäurechlorid,
  • Butylpropylcarbamidsäurechlorid,
  • Butylethylcarbamidsäurechlorid,
  • Dimethylthiocarbamidsäurechlorid,
  • Diethylthiocarbamidsäurechlorid,
  • Dipropylthiocarbamidsäurechlorid,
  • Dibutylthiocarbamidsäurechlorid,
  • Methylethylthiocarbamidsäurechlorid,
  • Methylpropylthiocarbamidsäurechlorid,
  • Methylbutylthiocarbamidsäurechlorid,
  • Ethylpropylthiocarbamidsäurechlorid,
  • Butylpropylcarbamidsäurechlorid,
  • Butylethylthiocarbamidsäurechlorid.
The starting compounds of the formula XII are preferably carbamic acid and thiocarbamic acid chlorides, the substituents R 1 , R 2 of which contain a short-chain hydrocarbon chain with 1-4 C atoms, for example:
  • Dimethyl carbamic acid chloride,
  • Diethyl carbamic acid chloride
  • Dipropylcarbamic acid chloride,
  • Dibutylcarbamic acid chloride,
  • Methyl ethyl carbamic acid chloride,
  • Methylpropylcarbamic acid chloride,
  • Methyl butyl carbamic acid chloride,
  • Ethyl propyl carbamic acid chloride,
  • Butylpropylcarbamic acid chloride,
  • Butylethyl carbamic acid chloride,
  • Dimethylthiocarbamic acid chloride,
  • Diethylthiocarbamic acid chloride,
  • Dipropylthiocarbamic acid chloride,
  • Dibutylthiocarbamic acid chloride,
  • Methylethylthiocarbamic acid chloride,
  • Methylpropylthiocarbamic acid chloride,
  • Methylbutylthiocarbamic acid chloride,
  • Ethyl propylthiocarbamic acid chloride,
  • Butylpropylcarbamic acid chloride,
  • Butylethylthiocarbamic acid chloride.

Die neuen substituierten Aminoalkanolphospolipide können z.B. zu pharmazeutischen Präparaten verarbeitet werden. Bei den pharmazeutischen Präparaten handelt es sich um solche zur enteralen wie oralen oder rektalen sowie parenteralen Verabreichung, welche die pharmazeutischen Wirkstoffe allein oder zusammen mit einem üblichen, pharmazeutisch anwendbaren Trägermaterial enthalten. Vorteilhafterweise liegt die pharmazeutische Zubereitung des Wirkstoffes in Form von Einzeldosen vor, die auf die gewünschte Verabreichung abgestimmt sind, wie z.B. Tabletten, Dragees, Kapseln, Suppositorien, Granulate, Lösungen, Emulsionen oder Suspensionen. Die Dosierung der Verbindungen liegt üblicherweise zwischen 1-1000 mg pro Dosis, vorzugsweise 1-10 mg je Dosis, und kann ein-oder mehrmals, bevorzugt zwei- bis dreimal, täglich verabreicht werden.The new substituted aminoalkanol phospholipids can e.g. processed into pharmaceutical preparations. The pharmaceutical preparations are those for enteral, oral, rectal and parenteral administration, which contain the active pharmaceutical ingredients alone or together with a customary, pharmaceutically usable carrier material. The pharmaceutical preparation of the active ingredient is advantageously in the form of single doses which are tailored to the desired administration, such as e.g. Tablets, coated tablets, capsules, suppositories, granules, solutions, emulsions or suspensions. The dosage of the compounds is usually between 1-1000 mg per dose, preferably 1-10 mg per dose, and can be administered one or more times, preferably two to three times, daily.

Die Herstellung der erfindungsgemässen Verbindungen wird durch die folgenden Beispiele näher erläutert:

  • A. Herstellung der Alkohole der Formel III
    • Beispiel 1
      • N-Benzyloxycarbonyl-N-methyl-2-aminoethanol.
      • 75 g 2- Methylamino -ethanol und 101g Triethylamin werden mit 1000 ml absol. Chloroform gemischt und zu dieser Lösung 171 g Chlorameisensäurebenzylester bei ca. 20°C zugetropft. Die Mischung wird 1 h bei Raumtemperatur gerührt, mit Wasser, verdünnter Salzsäure und nochmals mit Wasser gewaschen und über Natriumsulfat getrocknet. Nach Abdampfen der Lösungsmittel im Vakuum bleiben 173 g Öl zurück. IR (Film): 1695 cm-1
    • Beispiel 2
      • N-Benzyloxycarbonyl-N-undecyl-2-aminoethanol
        analog Beispiel 1 aus:
        • 124 g 2- Undecylamino -ethanol
        • 58 g Triethylamin
        • 500 ml Chloroform
        • 97 g Chlorameisensäurebenzylester.
      • Reinigung durch Säulenchromatographie (Kieselgel//Hexan/Essigsäureethylester).
      • Ausbeute: 113 g Öl mit IR (Film): 1683 cm-1
    • Beispiel 3
      • N-Benzyloxycarbonyl-N-hexadecyl-2-aminoethanol
        analog Beispiel 1 aus:
        • 71 g 2-Hexadecylamino-ethanol
        • 25 g Triethylamin
        • 250 ml Chloroform
        • 43 g Chlorameisensäurebenzylester.
      • Reinigung durch Säulenchromatographie (Kieselgel//Chloroform).
      • Ausbeute: 40,2 g Öl mit IR (Film): 1690 cm-1
    • Beispiel 4
      • N-Benzyl-N-octadecyl-2-aminoethanol.
      • In ein Gemisch aus 65,9 g N-Benzyl-octadecylamin und 200 ml Methanol werden bei Raumtemperatur innerhalb von 2 h 40 ml mit Trockeneis gekühltes Ethylenoxid zugetropft, die Mischung weitere 3 h gerührt, das Lösungsmittel abgezogen und der Rückstand durch Säulenchromatographie (Kieselgel/Chloroform) gereinigt.
      • Ausbeute: 73 g mit Schmp. 31 °C
    • Beispiel 5
      • N-Benzyloxycarbonyl-N-octadecyl-3-amino- propanol
        analog Beispiel 1 aus:
        • 34,2 g 3-Octadecylamino-propanol
        • 10,5 g Triethylamin
        • 100 ml Chloroform
        • 17,7 g Chlorameisensäurebenzylester.
      • Reinigung durch Säulenchromatographie (Kieselgel//Chloroform).
      • Ausbeute: 33,1 g Öl mit IR (Film): 1680 cm-1
    • Beispiel 6
      • N-Benzyloxycarbonyl-N-octadecyl-4-aminobutanol
        analog Beispiel 1 aus:
        • 24,8 g 4- Octadecylamino -butanol
        • 7,4 g Triethylamin
        • 200 ml Chloroform
        • 12,5 g Chlorameisensäurebenzylester.
      • Reinigung durch Säulenchromatographie (Kieselgel/Chloroform).
      • Ausbeute: 18 g Öl mit IR (Film): 1690 cm-1
    • Beispiel 7
      • N-Benzyloxycarbonyl-N-eicosyl-2-aminoethanol
        analog Beispiel 1 aus:
        • 32,8 2-Eicosylamino-ethanol
        • 9,7 g Triethylamin
        • 200 ml Chloroform
        • 16,3 g Chlorameisensäurebenzylester.
      • Reinigung durch Säulenchromatographie (Kieselgel//Hexan/Essigsäureethylester).
      • Ausbeute: 14,6g mit Schmp. 53-54°C, IR (Film): 1690 cm-1
      • Darstellung der Phospholipide der Formel IV.
    • Beispiel 8
      • N-Benzyloxycarbonyl-N-methyl-2-aminoethanol-phosphocholin.
        • a) In eine Mischung von 105g Dichlorphosphorsäure-2-bromethylester, 53 ml Pyridin und 800 ml absol. Chloroform werden 46 g N-Benzyloxycarbonyl-N-methyl-2-aminoethanol, gelöst in 220 ml Chloroform, unter Eiskühlung zugetropft. Die Reaktionsmischung wird 1 h unter Eiskühlung und nach Zugabe von Eiswasser eine weitere Stunde bei Raumtemperatur gerührt. Die organische Phase wird abgetrennt, mit Wasser neutral gewaschen, über Natriumsulfat getrocknet und eingeengt. Der Rückstand wird durch Säulenchromatographie (Kieselgel/Chloroform/ Methanol) gereinigt.
      • Ausbeute: 28g (N-Benzyloxycarbonyl-N-me- tyhl-2-aminoethyl)-2-bromethyl-phosphat (Öl).
        • b) 28 g (N-Benzyloxycarbonyl-N-methyl-2-aminoethyl)-2-bromethylphosphat werden in 300 ml trockenem Toluol gelöst, mit 30 ml 33%iger ethanolischer Trimethylaminlösung versetzt und die Mischung 4 h bei 60°C im Autoklaven gerührt. Anschliessend werden die Lösungsmittel am Rotavapor abgezogen und der Rückstand durch Säulenchromatographie (Kieselgel/Chloroform/ Methanol/Wasser) gereinigt.
      • Ausbeute: 8,5 g mit Schmp. 75-78°C.
    • Beispiel 9
      • N-Benzyloxycarbonyl-N-undecyl-2-aminoethanol-phosphocholin
        analog Beispiel 8 aus:
        • a) 75 g Dichlorphosphorsäure-2-bromethylester
          • 51 ml Pyridin
          • 600 ml Chloroform
          • 54,2 g N-Benzyloxycarbonyl-N-undecyl-2-aminoethanol in 150 ml Chloroform.
      • Ausbeute: 47,8 g (N-Benzyloxycarbonyl-N-undecyl-2-aminoethyl)-2-bromethyl-phosphat (Öl).
        • b) 47,6 g (N-Benzyloxycarbonyl-N-undecyl-2-aminoethyl)-2-bromethyl-phosphat.
          • 300 ml Toluol
          • 30 ml 33%ige ethanolische Trimethylaminlösung.
      • Ausbeute: 29,9 mit Schmp. 224-226°C IR (in KBr): 1692 cm-1
    • Beispiel 10
      • N-Benzyloxycarbonyl-N-hexadecyl-2-aminoethanol-phosphocholin
        analog Beispiel 8 aus:
        • a) 46 g Dichlorphosphorsäure-2-bromethylester
          • 23 ml Pyridin
          • 400 ml Chloroform
          • 40 g N-Benzyloxycarbonyl-N-hexadecyl-2-aminoethanol in 95 ml Chloroform.
      • Ausbeute: 21,5g (N-Benzyloxycarbonyl-N-hexadecyl-2-aminoethyl)-2-bromethyl-phosphat (Öl).
        • b) 21,4g (N-Benzyloxycarbonyl-N-hexadecyl-2-aminoethyl)-2-bromethyl-phosphat
          • 100 ml Toluol
          • 10 ml 33%ige ethanolische Trimethylaminlösung.
      • Ausbeute: 7 mit Schmp. 226-228°C IR (in KBr): 1691 cm-1
    • Beispiel 11
      • N-Benzyl-N-octadecyl-2-aminoethanol-phosphocholin.
        • a) In eine Mischung aus 10 g N-Benzyl-N-octadecyl-2-aminoethanol, 50 ml Chloroform und 5 g Triethylamin werden unter Eiskühlung 8,3 g Dichlorphosphorsäure-2-bromethylester eingetropft. Die Reaktionsmischung wird weitere 3 h bei Raumtemperatur und nach Zugabe von Eiswasser nochmals 1 h gerührt. Die organische Phase wird abgetrennt, mit Wasser neutral gewaschen, über Natriumsulfat getrocknet und eingeengt. Der Rückstand wird durch Säulenchromatographie (Kieselgel/Chloroform/Methanol) gereinigt.
      • Ausbeute: 9,2 g (N-Benzyl-N-octadecyl-2-- aminoethyl)-2-bromethylphosphat (Öl)
        • b) N-Benzyl-N-octadecyl-2-aminoethanol- phosphocholin
          • analog Beispiel 8b aus:
          • 9,2 g (N-Benzyl-N-octadecyl-2-aminoethyl)-2- bromethylphosphat
          • 30 ml Toluol
          • 5,2 ml 33%ige ethanolische Trimethylaminlösung.
      • Ausbeute: 6,4 g mit Schmp. 215-217°C.
    • Beispiel 12
      • N-Benzyloxycarbonyl-N-octadecyl-3-amino- propanol-(1)-phosphocholin
        analog Beispiel 8 aus:
        • a) 34,3 g Dichlorphosphorsäure-2-bromethyl- ester
          • 140 ml Pyridin
          • 140 ml Chloroform
          • 32,7 g N-Benzyloxycarbonyl-N-octadecyl-3-aminopropanol in 100 ml Chloroform.
      • Ausbeute: 9,6 g (N-Benzyloxycarbonyl-N-octadecyl-3-aminopropyl)-2-bromethyl-phosphat (Öl).
        • b) 9,5 g (N-Benzyloxycarbonyl-N-octadecyl-3-aminopropyl)-2-bromethyl-phosphat
          • 45 ml Toluol
          • 5 ml 33%ige ethanolische Trimethylaminlösung.
      • Ausbeute: 6,5 g mit Schmp. 219-223°C IR (in KBr): 1688 cm-1.
    • Beispiel 13
      • N-Benzyloxycarbonyl-N-octadecyl-4-aminobutanol-(1)-phosphocholin
        analog Beispiel 8 aus:
        • a) 17,4g Dichlorphosphorsäure-2-bromethyl- ester
          • 72 ml Pyridin
          • 72 ml Chloroform
          • 17 g N-Benzyloxycarbonyl-N-octadecyl-4-aminobutanol in 40 ml Chloroform.
      • Ausbeute:6,1 g (N-Benzyloxycarbonyl-N-octadecyl-4-aminobutyl)-2-bromethyl-phosphat (Öl).
        • b) 6 g (N-Benzyloxycarbonyl-N-octadecyl-4-aminobutyl)-2-bromethyl-phosphat
          • 30 ml Toluol
          • 3 ml 33%ige ethanolische Trimethylaminlösung.
      • Ausbeute: 4g mit Schmp. 220°C (Zers.) IR (in KBr): 1694 cm-1.
    • Beispiel 14
      • N-Benzyloxycarbonyl-N-eicosyl-2-aminoethanol-phosphocholin
        analog Beispiel 8 aus:
        • a) 14,5 g Dichlorphosphorsäure-2-bromethyle- ster
          • 7,5 ml Pyridin
          • 120 ml Chloroform
          • 14,5 g N-Benzyloxycarbonyl-N-eicosyl-2-aminoethanol in 30 ml Chloroform.
      • Ausbeute: 12,7 g (N-Benzyloxycarbonyl-N-eicosyl-2-aminoethyl)-2-bromethyl-phosphat (Öl).
        • b) 12.6 g (N-Benzyloxycarbonyl-N-eicosyl-2-aminoethyl)-2-bromethyl-phosphat
          • 60 ml Toluol
          • 20 ml 33%ige ethanolische Trimethylaminlösung.
      • Ausbeute:1 1,4 g mit Schmp. 210°C (Zers.) IR (in KBr): 1694 cm-1.
    • Beispiel 15
      • (N-Benzyl-N-octadecyl-2-aminoethyl)-2-tri- ethylammonioethylphosphat
        analog Beispiel 8b aus
        • 11,8 g (N-Benzyl-N-octadecyl-2-aminoethyl)-2- bromethyl-phosphat
        • 60 ml Toluol
        • 5 ml Triethylamin und 10 ml 2-Propanol.
      • Ausbeute: 10,2 g mit Schmp. 215-216°C.
    • Beispiel 16
      • (N-Benzyl-n-octadecyl-2-aminoethyl)-2-dimet- hylammonioethylphosphat
        analog Beispiel 8b aus:
        • 11,8g g (N-Benzyl-N-octadecyl-2-aminoethyl)-2- bromethyl-phosphat
        • 60 ml Toluol und 30 ml 2-Propanol
        • 10 ml 40%ige wässrige Dimethylaminlösung.
      • Ausbeute: 9,5 g mit Schmp. 210°C.
  • C. Herstellung der Phospholipide der Formel X
    • Beispiel 17
      • 2-Methylamino-ethanol-phosphocholin.
      • 8 g N-Benzyloxycarbonyl-N-methyl-2-aminoethanol-phosphocholin werden in 60 ml Dioxan und 15 ml Wasser gelöst, die Lösung mit 0,8 g 10%iger Palladium-/Aktivkohle versetzt und die Reaktionsmischung mit Wasserstoff hydriert. Nach Ende der H2-Aufnahme wird die Lösung filtriert und das Filtrat im Vakuum zur Trockene eingeengt.
      • Ausbeute: 5 g wachsartige Substanz.
    • Beispiel 18
      • 2-Undecylamino-ethanol-phosphocholin analog Beispiel 17 aus:
        • 14g N-Benzyloxycarbonyl-N-undecyl-2-aminoethanol-phosphocholin und
        • 1,4g Pd-Aktivkohle in Dioxan/Wasser = 4:1 (V/V).
      • Ausbeute: 9,2 g mit Schmp. 205-208°C.
    • Beispiel 19
      • 2-Hexadecylamino-ethanol-phosphocholin analog Beispiel 17 aus:
        • 6,9 g N-Benzyloxycarbonyl-N-hexadecyl-2-aminoethanol-phosphocholin und
        • 0,7 g Pd-Aktivkohle in Dioxan/Wasser = 4:1 (V/V).
      • Ausbeute: 5,2 g mit Schmp. 203-207°C (Zers.).
    • Beispiel 20
      • 2-Octadecylamino-ethanol-phosphocholin analog Beispiel 17 aus:
        • 6,4 g N-Benzyl-N-octadecyl-2-aminoethanol- phosphocholin und
        • 0,6g Pd-Aktivkohle in Dioxan/Wasser = 4:1 (V/V).
      • Ausbeute: 5 g mit Schmp. 210-212°C.
    • Beispiel 21
      • 3-Octadecylamino-propanoi-phosphocholin analog Beispiel 17 aus:
        • 6,2 g N-Benzylocycarbonyl-N-octadecyl-3-ami- nopropanol-phosphocholin und
        • 0,6g Pd-Aktivkohle in Dioxan/Wasser = 4:1 (V/V).
      • Ausbeute: 4,4 g mit Schmp. 227-229°C.
    • Beispiel 22
      • 4-Octadecylamino-butanol-phosphocholin analog Beispiel 17 aus:
        • 3,7 g N-Benzyloxycarbonyl-N-octadecyl-4-aminobutanol-phosphocholin und
        • 0,4g Pd-Aktivkohle in Dioxan/Wasser = 4:1 (V/V).
      • Ausbeute: 2,2 g mit Schmp. 208-210°C.
    • Beispiel 23
      • 2-Eicosylamino-ethanol-phosphocholin analog Beispiel 17 aus:
        • 11 g N-Benzyloxycarbonyl-N-eicosyl-2-aminoethanol-phosphocholin und
        • 1,1 g Pd-Aktivkohle in Dioxan/Wasser = 4:1 (V/V).
      • Ausbeute: 7,4 g mit Schmp. 214-219°C.
    • Beispiel 24
      • (N-Octadecyl-2-aminoethyl)-2-triethylammo- nioethyl-phosphat
        analog Beispiel 17 aus:
        • 10 g (N-Benzyl-N-octadecyl-2-aminoethyl)-2- triethylammonioethyl-phosphat und
        • 1 g Pd-Aktivkohle in Dioxan/Wasser = 4:1 (V/V).
      • Ausbeute: 8,1 g mit Schmp. 218-219°C.
    • Beispiel 25
      • (N-Octadecyl-2-aminoethyl)-2-dimethylam- monioethyl-phosphat
        analog Beispiel 17 aus:
        • 9,3 g (N-Benzyl-N-octadecyl-2-aminoethyl)-2-di- methylammonioethyl-phosphat und
        • 0,9 g Pd-Aktivkohle in Dioxan/Wasser = 4:1 (V/V).
      • Ausbeute: 7,5 g mit Schmp. 220-223°C.
  • D. Herstellung der Phospholipide der Formel
    • Beispiel 26
      • 2-(3-Ethyl-1-octadecylureido)-ethanol-phosphocholin.
      • 0,5 g 2-Octadecylamino-ethanol-phosphocholin werden in 10 ml Chloroform gelöst, die Lösung mit 0,14 g Ethylisocyanat und einigen Tropfen Dimethylformamid versetzt und ca. 4 bei Raumtemperatur gerührt. Die Lösung wird im Vakuum eingeengt und der Rückstand durch Säulenchromatographie (Kieselgel//Chloroform/Methanoi/ Wasser) gereinigt.
      • Ausbeute: 0,43 g mit Schmp. 214-215°C IR (in KBr): 1630, 1535 cm-1.
    • Beispiel 27
      • 2-(3-Methyl-1-octadecylureido)-ethanol-phosphocholin
        analog Beispiel 26 aus:
        • 0,5 g 2-Octadecylamino-ethanol-phosphocholin
        • 0,11 g Methylisocyanat
        • 10 ml Chloroform.
      • Ausbeute: 0,35 g mit Schmp. 219-220°C IR (in KBr): 1625,1540 cm-1.
    • Beispiel 28
      • 2-(3-Metyhl-1-octadecylthioureido)-ethanol-phosphocholin
        analog Beispiel 26 aus:
        • 0,5 g 2-Octadecylamino-ethanol-phosphocholin
        • 0,15 g Methylisothiocyanat
        • 10 ml Chloroform.
      • Ausbeute: 0,41 g mit Schmp. 215-217°C.
    • Beispiel 29
      • 2-(3,3-Dimethyl-1-octadecylureido)-ethanol-phosphocholin.
      • 0,5 g 2-Octadecylamino-ethanol-phosphocholin werden in 10 ml Chloroform gelöst, die Lösung mit 0,21 g Dimethylcarbamidsäurechlorid und 0,14g Silbercarbonat versetzt und ca. 12h bei Raumtemperatur gerührt. Die Lösung wird im Vakuum eingeengt und der Rückstand durch Säulenchromatographie (Kieselgel/Chloroform/ Methanol/Wasser) gereinigt.
      • Ausbeute: 0,31 g mit Schmp. 215-216°c IR (in KBr) 1634cm-1.
    • Beispiel 30
      • 2-(3-Butyl-1-octadecylureido)-ethanol-phosphocholin
        analog Beispiel 26 aus:
        • 0,5 g 2-Octadecylamino-ethanol-phosphocholin
        • 0,2 g Butylisocyanat
        • 10 ml Chloroform.
      • Ausbeute: 0,38 g mit Schmp. 208-210°C IR (in KBr): 1625, 1530 cm-1.
    • Beispiel 31
      • 2-(3-Hexadecyl-1-octadecylureido)-ethanol-phosphocholin
        analog Beispiel 26 aus:
        • 0,5 g 2-Octadecylamino-ethanol-phosphocholin
        • 0,6 g Hexadecylisocyanat
        • 10 ml Chloroform.
      • Ausbeute: 0,63 g mit Schmp. 200-203°C IR (in KBr): 1625, 1535cm-1.
    • Beispiel 32
      • 2-(3-Benzyl-1-octadecylureido)-ethanol-phosphocholin
        analog Beispiel 26 aus:
        • 0,5 g 2-Octadecylamino-ethanol-phosphocholin
        • 0,27 g Benzylisocyanat
        • 10 ml Chloroform.
      • Ausbeute: 0,42 g mit Schmp. 221-222°C.
    • Beispiel 33
      • 2-(3-Methyl-1-undecylureido)-ethanol-phosphocholin
        analog Beispiel 26 aus:
        • 0,5 g 2-Undecylamino-ethanol-phosphocholin
        • 0,15 g Methylisocyanat
        • 10 ml Chloroform.
      • Ausbeute: 0,3g wachsartige Substanz mit Klarpunkt~185°C
        • IR (in KBr): 1629, 1540 cm-1.
    • Beispiel 34
      • 2-(3-Ethyl-1-undecylureido)-ethanol-phosphocholin
        analog Beispiel 26 aus:
        • 0,5 g 2-Undecylamino-ethanol-phosphocholin
        • 0,18 g Ethylisocyanat
        • 10 ml Chloroform.
      • Ausbeute: 0,3g wachsartige Substanz mit Klarpunkt ~180-183°C
        • IR (in KBr): 1626, 1536 cm-1.
    • Beispiel 35
      • 2-(3,3-Dimethyl-1-undecylureido)-ethanol-phosphocholin
        analog Beispiel 29 aus:
        • 0,5 g 2-Undecylamino-ethanol-phosphocholin
        • 0,28 g Dimethylcarbamidsäurechlorid
        • 0,18 g Silbercarbonat
        • 10 ml Chloroform.
      • Ausbeute: 0,32 wachsartige Substanz mit Klarpunkt: 203-204°C
        • IR (in KBr): 1634cm-1.
    • Beispiel 36
      • 2-(3-Methyl-1-undecylthioreido)-ethanol-phosphocholin
        analog Beispiel 26 aus:
        • 0,5 g 2-Undecylamino-ethanol-phosphocholin
        • 0,19 g Methylisothiocyanat
        • 10 ml Chloroform.
      • Ausbeute: 0,33g wachsartige Substanz mit Klarpunkt~165°C.
    • Beispiel 37
      • 2-(3-Phenyl-1-undecylureido)-ethanol-phosphocholin
        analog Beispiel 26 aus:
        • 0,5 g 2-Undecylamino-ethanol-phosphocholin
        • 0,31 g Phenylisocyanat
        • 10 ml Chloroform.
      • Ausbeute: 0,61 g wachsartige Substanz IR (in KBr): 1649,1538 cm-1.
    • Beispiel 38
      • 2-(3-Benzyl-1-undecylureido)-ethanol-phosphocholin
      • analog Beispiel 26 aus:
        • 1,5 g 2-Undecylamino-ethanol-phosphocholin
        • 1,1 g Benzylisocyanat
        • 30 ml Chloroform.
      • Ausbeute: 1,7 g wachsartige Substanz IR (in KBr): 1533,1628 cm-1.
    • Beispiel 39
      • 2-(3-Hexadecyl-1-undecylureido)-ethanol-phosphocholin
        analog Beispiel 26 aus:
        • 0,5 g 2-Undecylamino-ethanol-phosphocholin
        • 0,7 g Hexadecylisocyanat
        • 10 ml Chloroform.
      • Ausbeute: 0,69 mit Schmp. 196-199°C IR (in KBr): 1622,1533 cm-i.
    • Beispiel 40
      • 2-(3-Oleyl-1-undecylureido)-ethanol-phosphocholin
        analog Beispiel 26 aus:
        • 0,5 g 2-Undecylamino-ethanol-phosphocholin
        • 0,8 g Oleylisocyanat
        • 10 ml Chloroform unter Stickstoff.
      • Ausbeute: 0,61 g wachsartige Substanz.
    • Beispiel 41
      • 2-(1-Hexadecyl-3-methylureido)-ethanol-phosphocholin
        analog Beispiel 26 aus:
        • 0,3 g 2-Hexadecylamino-ethanol-phosphocholin
        • 0,08 g Methylisocyanat
        • 5 ml Chloroform.
      • Ausbeute: 0,22 g mit Schmp. 215-218°C IR (in KBr): 1635, 1540 cm-1.
    • Beispiel 42
      • 2-(3-Ethyl-1-hexadecylureido)-ethanol-phosphocholin
        analog Beispiel 26 aus:
        • 0,5 g 2-Hexadecylamino-ethanol-phosphocholin
        • 0,15 g Ethylisocyanat
        • 10 ml Chloroform.
      • Ausbeute: 0,45 g mit Schmp. 213-217°C.
    • Beispiel 43
      • 2-(1-Hexadecyl-3-methylthioureido)-ethanol-phosphocholin
        analog Beispiel 26 aus:
        • 0,5 g 2-Hexadecylamino-ethanol-phosphocholin
        • 0,16 g Methylisothiocyanat
        • 10 ml Chloroform.
      • Ausbeute: 0,2 g mit Schmp. 210-212°C.
    • Beispiel 44
      • 2-(3,3-Dimethyl-1-hexadecylureido)-ethanol-phosphocholin
        analog Beispiel 29 aus:
        • 0,3 g 2-Hexadecylamino-ethanol-phosphocholin
        • 0,24 g Dimethylcarbamidsäurechlorid
        • 0,1 g Silbercarbonat
        • 5 ml Chloroform.
      • Ausbeute: 0,15 g mit Schmp. 208-211 °C IR (in KBr): 1635 cm-1.
    • Beispiel 45
      • 3-(3-Methyl-1-octadecylureido)-propanol-(1)-phosphocholin
        analog Beispiel 26 aus:
        • 0,5 g 3-Octadecylamino-propanol-(1)-phosphocholin
        • 0,11 g Methylisocyanat
        • 10 ml Chloroform.
      • Ausbeute: 0,43 g mit Schmp. 221-224°C IR (in KBr): 1628,1540 cm-i.
    • Beispiel 46
      • 3-(3-Ethyl-1-octadecyiureido)-propanol-(1)-phosphocholin
        analog Beispiel 26 aus:
        • 0,5 g 3-Octadecylamino-propanol-(1)-phosphocholin
        • 0,14 g Ethylisocyanat
        • 10 ml Chloroform.
      • Ausbeute: 0,3 g mit Schmp. 215-218°C IR (in KBr): 1626, 1535cm-1.
    • Beispiel 47
      • 3-(3,3-Dimethyl-1-octadecylureido)-propanol-(1)-phosphocholin
        analog Beispiel 29 aus:
        • 0,5 g 3-Octadecylamino-propanol-(1)-phosphocholin
        • 0,18 g Dimethylcarbamidsäurechlorid
        • 0,14 g Silbercarbonat
        • 10 ml Chloroform.
      • Ausbeute: 0,28 g mit Schmp. 224-225°C IR (in KBr): 1633 cm-1.
    • Beispiel 48
      • 3-(3-Methyl-1-octadecylthioureido)-propanol-(1)-phosphocholin
        analog Beispiel 26 aus:
        • 0,5 g 3-Octadecylamino-propanol-(1)-phosphocholin
        • 0,15 g Methylisothiocyanat
        • 10 ml Chloroform.
      • Ausbeute: 0,36 g mit Schmp. 210-212°C.
    • Beispiel 49
      • 4-(3-Methyl-1-octadecylureido)-butanol-(1)-phosphocholin
        analog Beispiel 26 aus:
        • 0,5 g 4-Octadecylamino-butanol-(1)-phosphocholin
        • 0,11 g Methylisocyanat
        • 10 ml Chloroform.
      • Ausbeute: 0,4 g mit Schmp. 226-230°C IR (in KBr): 1629,1541 cm-1.
    • Beispiel 50
      • 4-(3-Ethyl-1-octadecylureido)-butanol-(1)-phosphocholin
        analog Beispiel 26 aus:
        • 0,3 g 4-Octadecylamino-butanol-(1)-phosphocholin
        • 0,1 g Ethylisocyanat
        • 5 ml Chloroform.
      • Ausbeute: 0,25 g mit Schmp. 215-216°C IR (in KBr): 1623, 1532cm-1.
    • Beispiel 51
      • 4-(3,3-Dimethyl-1-octadecyl)-butanol-(1)-phosphocholin
        ananolg Beispiel 29 aus:
        • 0,3 g 4-Oxtadecylamino-butanol-(1)-phosphocholin
        • 0,13 g Dimethylcarbamidsäurechlorid
        • 0,1 g Silbercarbonat
        • 5 ml Chloroform.
      • Ausbeute: 0,15 g mit Schmp. 234-236°C IR (in KBr): 1632 cm-'.
    • Beispiel 52
      • 4-(3-Methyl-1-octadecylthioureido)-butanol-(1)-phosphocholin
        analog Beispiel 26 aus:
        • 0,3 g 4-Octadecylamino-butanol-(1)-phosphocholin
        • 0,1 g Methylisothiocyanat
        • 10 ml Chloroform.
      • Ausbeute: 0,21 g mit Schmp. 221-224°C.
    • Beispiel 53
      • 2-(1-Eicosyl-3-methylureido)-ethanol-phosphocholin
        analog Beispiel 26 aus:
        • 0,5 g 2-Eicosylamino-ethanol-phosphocholin
        • 0,11 g Methylisocyanat
        • 10 ml Chloroform.
      • Ausbeute: 0,35 g mit Schmp. 222-224°C.
    • Beispiel 54
      • 2-(1-Eicosyl-3-ethylureido)-ethanol-phosphocholin
        analog Beispiel 26 aus:
        • 0,5 g 2-Eicosylamino-ethanol-phosphocholin
        • 0,14g Ethylisocyanat
        • 10 ml Chloroform.
      • Ausbeute: 0,4 g mit Schmp. 218-220°C.
    • Beispiel 55
      • 2-(3,3-Dimethyl-1-eicosylureido)-ethanol-phosphocholin
        analog Beispiel 29 aus:
        • 0,5 g 2-Eicosylamino-ethanol-phosphocholin
        • 0,21 g Dimethylcarbamidsäurechlorid
        • 0,14g Silbercarbonat
        • 10 ml Chloroform.
      • Ausbeute: 0,3 g mit Schmp. 215-217°C.
    • Beispiel 56
      • 2-(1-Eicosyl-3-methylthioureido)-ethanol-phosphocholin
        analog Beispiel 26 aus:
        • 0,5 g 2-Eicosylamino-ethanol-phosphocholin
        • 0,15 g Methylisothiocyanat
        • 10 ml Chloroform.
      • Ausbeute: 0,3 g mit Schmp. 210-211 °C.
    • Beispiel 57
      • 2-(1-Undecylureido)-ethanol-phosphocholin analog Beispiel 17 aus:
        • 1,2 g 2-(3-Benzyl-1-undecylureida)-ethanol-phosphocholin und
        • 0,72 g Pd-Aktivkohle, die in 6 Portionen innerhalb von 20 h zugegeben werden, in Dioxan/Wasser = 4:1 (V/V).
      • Ausbeute: 0.5 g wachsartige Substanz IR (in KBr): 1652,1597 cm-1.
    • Beispiel 58
      • [2-(3-Methyl-1-octadecylureido)-ethyl]-(2- triethylammonioethyl)-phosphat
        analog Beispiel 26 aus:
        • 0,5 g (N-Octadecyl-2-aminoethyl)-2-triethylam- monioethyl-phosphat
        • 0,11 g Methylisocyanat
        • 10 ml Chloroform,
      • Ausbuete: 0,41 g mit Schmp. 220-221°C.
    • Beispiel 59
      • [2-(3-Methyl-1-octadecylureido)-ethyl]-(2-di- methylammonioethyl)-phosphat
        analog Beispiel 26 aus:
        • 0,5 g (N-Octadecyl-2-aminoethyl)-2-dimethylam- monioethyl-phosphat
        • 0,11 g Methylisocyanat
        • 10 ml Chloroform.
      • Ausbeute: 0,35 g mit Schmp. 215-216°C.
    • Beispiel 60
      • 2-(3-Nexadecyl-1-methylureido)-ethanol-phosphocholin.
      • 0,5 g 2-Methylamino-ethanol-phosphocholin werden in 10 ml N-Methylacetamid gelöst, die Lösung mit 1,08g Hexadecylisocyanat versetzt und 24h bei Raumtemperatur gerührt. Die Lösung wird im Vakuum eingeengt und der Rückstand durch Säulenchromatographie (Kieselgel// Chloroform/Methanol/Wasser)
      • gereinigt.
      • Ausbeute: 0,3 g mit Schmp. 210-213°C.
      • Analog Beispiel 60 werden hergestellt:
        • 2-(1-Methyl-3-octadecylureido)-ethanol-phosphocholin
        • 2-(3-Eicosyl-1-methylureido)-ethanol-phosphocholin
        • 2-(1-Methyl-3-oleylureido)-ethanol-phosphocholin
    • Beispiel 61
      • N-Methoxycarbonyl-N-octadecyl-2-aminoethanol-(1 )-phosphocholin.
      • 50 mg N-Octadecyl-2-aminoethanol-(1)-phosphocholin werden in 2 ml Chloroform gelöst, 20mg Chlorameisensäuremethylester und 5 Tropfen Triethylamin hinzugefügt. Die Mischung wird eine Stunde bei Raumtemperatur gerührt, im Vakuum eingeengt und der Rückstand durch Säulenchromatographie (Kieselgel//Chloroform/ Methanol/Wasser) gereinigt.
      • Ausbeute: 41 mg wachsartige Substanz IR (in KBr): 1692cm-1.
    • Beispiel 62
      • N-Ethoxycarbonyl-N-octadecyl-2-aminoethanol-(1 )-phosphocholin
        anaolg Beispiel 61 aus:
        • 50 mg N-Octadecyl-2-aminoethanol-(1)-phosphocholin
        • 20 mg Chlorameisensäureethylester
        • 5 Tropfen Triethylamin
        • in 2 ml Chloroform.
      • Ausbeute: 39 mg wachsartige Substanz IR (in KBr): 1690 cm-1.
    • Beispiel 63
      • N-Benzyloxycarbonyl-N-octadecyl-2-aminoethanol-(1)-phosphocholin analog Beispiel 61 aus:
        • 50 mg N-Octadecyl-2-aminoethanol-(1)-phosphocholin
        • 34 mg Chlorameisensäurebenzylester
        • 5 Tropfen Triethylamin
        • in 2 ml Chloroform.
      • Ausbeute: 55 mg mit Schmp. 211 °C.
The preparation of the compounds according to the invention is explained in more detail by the following examples:
  • A. Preparation of the alcohols of the formula III
    • example 1
      • N-benzyloxycarbonyl-N-methyl-2-aminoethanol.
      • 75 g of 2-methylaminoethanol and 101g of triethylamine are absolute with 1000 ml. Chloroform mixed and 171 g of benzyl chloroformate added dropwise to this solution at about 20 ° C. The mixture is stirred at room temperature for 1 h, washed with water, dilute hydrochloric acid and again with water and dried over sodium sulfate. After evaporation of the solvents in vacuo, 173 g of oil remain. IR (film): 1695 cm- 1
    • Example 2
      • N-benzyloxycarbonyl-N-undecyl-2-aminoethanol
        analogous to example 1 from:
        • 124 g of 2-undecylaminoethanol
        • 58 g triethylamine
        • 500 ml chloroform
        • 97 g of benzyl chloroformate.
      • Purification by column chromatography (silica gel // hexane / ethyl acetate).
      • Yield: 113 g of oil with IR (film): 1683 cm -1
    • Example 3
      • N-benzyloxycarbonyl-N-hexadecyl-2-aminoethanol
        analogous to example 1 from:
        • 71 g of 2-hexadecylaminoethanol
        • 25 g triethylamine
        • 250 ml chloroform
        • 43 g of benzyl chloroformate.
      • Purification by column chromatography (silica gel // chloroform).
      • Yield: 40.2 g of oil with IR (film): 1690 cm- 1
    • Example 4
      • N-benzyl-N-octadecyl-2-aminoethanol.
      • 40 ml of ethylene oxide cooled with dry ice are added dropwise to a mixture of 65.9 g of N-benzyloctadecylamine and 200 ml of methanol at room temperature within 2 h, the mixture is stirred for a further 3 h, the solvent is stripped off and the residue is purified by column chromatography (silica gel / Chloroform).
      • Yield: 73 g with mp. 31 ° C.
    • Example 5
      • N-benzyloxycarbonyl-N-octadecyl-3-aminopropanol
        analogous to example 1 from:
        • 34.2 g of 3-octadecylamino propanol
        • 10.5 g triethylamine
        • 100 ml chloroform
        • 17.7 g of benzyl chloroformate.
      • Purification by column chromatography (silica gel // chloroform).
      • Yield: 33.1 g of oil with IR (film): 1680 cm- 1
    • Example 6
      • N-benzyloxycarbonyl-N-octadecyl-4-aminobutanol
        analogous to example 1 from:
        • 24.8 g of 4-octadecylamino-butanol
        • 7.4 g triethylamine
        • 200 ml chloroform
        • 12.5 g benzyl chloroformate.
      • Purification by column chromatography (silica gel / chloroform).
      • Yield: 18 g of oil with IR (film): 1690 cm -1
    • Example 7
      • N-benzyloxycarbonyl-N-eicosyl-2-aminoethanol
        analogous to example 1 from:
        • 32.8 2-eicosylaminoethanol
        • 9.7 g triethylamine
        • 200 ml chloroform
        • 16.3 g benzyl chloroformate.
      • Purification by column chromatography (silica gel // hexane / ethyl acetate).
      • Yield: 14.6 g with mp 53-54 ° C, IR (film): 1690 cm -1
      • Representation of the phospholipids of formula IV.
    • Example 8
      • N-benzyloxycarbonyl-N-methyl-2-aminoethanol phosphocholine.
        • a) In a mixture of 105 g of dichlorophosphoric acid 2-bromomethyl ester, 53 ml of pyridine and 800 ml of absolute. Chloroform, 46 g of N-benzyloxycarbonyl-N-methyl-2-aminoethanol, dissolved in 220 ml of chloroform, are added dropwise with ice cooling. The reaction mixture is stirred for 1 h while cooling with ice and after adding ice water for a further hour at room temperature. The organic phase is separated off, washed neutral with water, dried over sodium sulfate and concentrated. The residue is purified by column chromatography (silica gel / chloroform / methanol).
      • Yield: 28g (N-benzyloxycarbonyl-N-methyl-2-aminoethyl) -2-bromethyl-phosphate (oil).
        • b) 28 g (N-benzyloxycarbonyl-N-methyl-2-aminoethyl) -2-bromethylphosphate are dissolved in 300 ml of dry toluene, 30 ml of 33% ethanolic trimethylamine solution are added and the mixture is stirred in an autoclave at 60 ° C. for 4 h . The solvents are then stripped off on a Rotavapor and the residue is purified by column chromatography (silica gel / chloroform / methanol / water).
      • Yield: 8.5 g with mp. 75-78 ° C.
    • Example 9
      • N-benzyloxycarbonyl-N-undecyl-2-aminoethanol phosphocholine
        analogous to example 8 from:
        • a) 75 g of 2-bromoethyl dichlorophosphate
          • 51 ml pyridine
          • 600 ml chloroform
          • 54.2 g of N-benzyloxycarbonyl-N-undecyl-2-aminoethanol in 150 ml of chloroform.
      • Yield: 47.8 g (N-benzyloxycarbonyl-N-undecyl-2-aminoethyl) -2-bromethyl-phosphate (oil).
        • b) 47.6 g (N-benzyloxycarbonyl-N-undecyl-2-aminoethyl) -2-bromethyl-phosphate.
          • 300 ml toluene
          • 30 ml of 33% ethanolic trimethylamine solution.
      • Yield: 29.9 with mp. 224-226 ° C IR (in KBr): 1692 cm -1
    • Example 10
      • N-benzyloxycarbonyl-N-hexadecyl-2-aminoethanol phosphocholine
        analogous to example 8 from:
        • a) 46 g of 2-bromoethyl dichlorophosphate
          • 23 ml pyridine
          • 400 ml chloroform
          • 40 g of N-benzyloxycarbonyl-N-hexadecyl-2-aminoethanol in 95 ml of chloroform.
      • Yield: 21.5 g (N-benzyloxycarbonyl-N-hexadecyl-2-aminoethyl) -2-bromethyl-phosphate (oil).
        • b) 21.4g (N-benzyloxycarbonyl-N-hexadecyl-2-aminoethyl) -2-bromethyl-phosphate
          • 100 ml toluene
          • 10 ml of 33% ethanolic trimethylamine solution.
      • Yield: 7 with mp 226-228 ° C IR (in KBr): 1691 cm -1
    • Example 11
      • N-benzyl-N-octadecyl-2-aminoethanol phosphocholine.
        • a) 8.3 g of dichlorophosphoric acid 2-bromoethyl ester are added dropwise to a mixture of 10 g of N-benzyl-N-octadecyl-2-aminoethanol, 50 ml of chloroform and 5 g of triethylamine while cooling with ice. The reaction mixture is stirred for a further 3 h at room temperature and after adding ice water for a further 1 h. The organic phase is separated off, washed neutral with water, dried over sodium sulfate and concentrated. The residue is purified by column chromatography (silica gel / chloroform / methanol).
      • Yield: 9.2 g (N-benzyl-N-octadecyl-2-- aminoethyl) -2-bromethylphosphate (oil)
        • b) N-benzyl-N-octadecyl-2-aminoethanol phosphocholine
          • analogous to example 8b from:
          • 9.2 g (N-benzyl-N-octadecyl-2-aminoethyl) -2-bromethyl phosphate
          • 30 ml toluene
          • 5.2 ml of 33% ethanolic trimethylamine solution.
      • Yield: 6.4 g with mp. 215-217 ° C.
    • Example 12
      • N-benzyloxycarbonyl-N-octadecyl-3-aminopropanol (1) phosphocholine
        analogous to example 8 from:
        • a) 34.3 g of 2-bromoethyl dichlorophosphoric ester
          • 140 ml pyridine
          • 140 ml chloroform
          • 32.7 g of N-benzyloxycarbonyl-N-octadecyl-3-aminopropanol in 100 ml of chloroform.
      • Yield: 9.6 g (N-benzyloxycarbonyl-N-octadecyl-3-aminopropyl) -2-bromethyl-phosphate (oil).
        • b) 9.5 g (N-benzyloxycarbonyl-N-octadecyl-3-aminopropyl) -2-bromethyl-phosphate
          • 45 ml toluene
          • 5 ml of 33% ethanolic trimethylamine solution.
      • Yield: 6.5 g with mp 219-223 ° C IR (in KBr): 1688 cm -1 .
    • Example 13
      • N-benzyloxycarbonyl-N-octadecyl-4-aminobutanol (1) phosphocholine
        analogous to example 8 from:
        • a) 17.4g dichlorophosphoric acid 2-bromethyl ester
          • 72 ml pyridine
          • 72 ml chloroform
          • 17 g of N-benzyloxycarbonyl-N-octadecyl-4-aminobutanol in 40 ml of chloroform.
      • Yield: 6.1 g (N-benzyloxycarbonyl-N-octadecyl-4-aminobutyl) -2-bromethyl-phosphate (oil).
        • b) 6 g (N-benzyloxycarbonyl-N-octadecyl-4-aminobutyl) -2-bromethyl-phosphate
          • 30 ml toluene
          • 3 ml of 33% ethanolic trimethylamine solution.
      • Yield: 4g with mp. 220 ° C (dec.) IR (in KBr): 1694 cm -1 .
    • Example 14
      • N-benzyloxycarbonyl-N-eicosyl-2-aminoethanol phosphocholine
        analogous to example 8 from:
        • a) 14.5 g of dichlorophosphoric acid 2-bromomethyl ester
          • 7.5 ml pyridine
          • 120 ml chloroform
          • 14.5 g of N-benzyloxycarbonyl-N-eicosyl-2-aminoethanol in 30 ml of chloroform.
      • Yield: 12.7 g (N-benzyloxycarbonyl-N-eicosyl-2-aminoethyl) -2-bromethyl-phosphate (oil).
        • b) 12.6 g (N-benzyloxycarbonyl-N-eicosyl-2-aminoethyl) -2-bromethyl-phosphate
          • 60 ml of toluene
          • 20 ml of 33% ethanolic trimethylamine solution.
      • Yield: 1 1.4 g with mp 210 ° C (dec.) IR (in KBr): 1694 cm -1 .
    • Example 15
      • (N-benzyl-N-octadecyl-2-aminoethyl) -2-triethylammonioethyl phosphate
        analogous to Example 8b
        • 11.8 g (N-benzyl-N-octadecyl-2-aminoethyl) -2-bromethyl-phosphate
        • 60 ml of toluene
        • 5 ml triethylamine and 10 ml 2-propanol.
      • Yield: 10.2 g with mp. 215-216 ° C.
    • Example 16
      • (N-benzyl-n-octadecyl-2-aminoethyl) -2-dimethylammonioethyl phosphate
        analogous to example 8b from:
        • 11.8g g (N-benzyl-N-octadecyl-2-aminoethyl) -2-bromethyl-phosphate
        • 60 ml toluene and 30 ml 2-propanol
        • 10 ml 40% aqueous dimethylamine solution.
      • Yield: 9.5 g with mp. 210 ° C.
  • C. Preparation of the Phospholipids of Formula X
    • Example 17
      • 2-methylaminoethanolphosphocholine.
      • 8 g of N-benzyloxycarbonyl-N-methyl-2-aminoethanol-phosphocholine are dissolved in 60 ml of dioxane and 15 ml of water, the solution is mixed with 0.8 g of 10% palladium / activated carbon and the reaction mixture is hydrogenated with hydrogen. After the H 2 uptake has ended, the solution is filtered and the filtrate is evaporated to dryness in vacuo.
      • Yield: 5 g of waxy substance.
    • Example 18
      • 2-Undecylamino-ethanol-phosphocholine analogous to Example 17 from:
        • 14g of N-benzyloxycarbonyl-N-undecyl-2-aminoethanol-phosphocholine and
        • 1.4g Pd activated carbon in dioxane / water = 4: 1 (V / V).
      • Yield: 9.2 g with mp. 205-208 ° C.
    • Example 19
      • 2-Hexadecylamino-ethanol-phosphocholine analogous to Example 17 from:
        • 6.9 g of N-benzyloxycarbonyl-N-hexadecyl-2-aminoethanol-phosphocholine and
        • 0.7 g Pd activated carbon in dioxane / water = 4: 1 (V / V).
      • Yield: 5.2 g with mp. 203-207 ° C (dec.).
    • Example 20
      • 2-octadecylamino-ethanol-phosphocholine analogous to Example 17 from:
        • 6.4 g of N-benzyl-N-octadecyl-2-aminoethanol-phosphocholine and
        • 0.6g Pd activated carbon in dioxane / water = 4: 1 (V / V).
      • Yield: 5 g with mp. 210-212 ° C.
    • Example 21
      • 3-octadecylamino-propano-phosphocholine analogous to Example 17 from:
        • 6.2 g of N-benzylocycarbonyl-N-octadecyl-3-aminopropanol-phosphocholine and
        • 0.6g Pd activated carbon in dioxane / water = 4: 1 (V / V).
      • Yield: 4.4 g with mp. 227-229 ° C.
    • Example 22
      • 4-octadecylamino-butanol-phosphocholine analogous to Example 17 from:
        • 3.7 g of N-benzyloxycarbonyl-N-octadecyl-4-aminobutanol-phosphocholine and
        • 0.4g Pd activated carbon in dioxane / water = 4: 1 (V / V).
      • Yield: 2.2 g with mp. 208-210 ° C.
    • Example 23
      • 2-Eicosylamino-ethanol-phosphocholine analogous to Example 17 from:
        • 11 g of N-benzyloxycarbonyl-N-eicosyl-2-aminoethanol-phosphocholine and
        • 1.1 g Pd activated carbon in dioxane / water = 4: 1 (V / V).
      • Yield: 7.4 g with mp. 214-219 ° C.
    • Example 24
      • (N-octadecyl-2-aminoethyl) -2-triethylammonioethyl phosphate
        analogous to example 17 from:
        • 10 g (N-benzyl-N-octadecyl-2-aminoethyl) -2-triethylammonioethyl phosphate and
        • 1 g Pd activated carbon in dioxane / water = 4: 1 (V / V).
      • Yield: 8.1 g with mp. 218-219 ° C.
    • Example 25
      • (N-octadecyl-2-aminoethyl) -2-dimethylam monioethyl phosphate
        analogous to example 17 from:
        • 9.3 g (N-benzyl-N-octadecyl-2-aminoethyl) -2-dimethylammonioethyl phosphate and
        • 0.9 g Pd activated carbon in dioxane / water = 4: 1 (V / V).
      • Yield: 7.5 g with mp 220-223 ° C.
  • D. Preparation of the Phospholipids of Formula
    • Example 26
      • 2- (3-ethyl-1-octadecylureido) ethanol phosphocholine.
      • 0.5 g of 2-octadecylaminoethanolphosphocholine are dissolved in 10 ml of chloroform, 0.14 g of ethyl isocyanate and a few drops of dimethylformamide are added to the solution, and the mixture is stirred at room temperature for about 4 hours. The solution is concentrated in vacuo and the residue is purified by column chromatography (silica gel // chloroform / methanoi / water).
      • Yield: 0.43 g with mp. 214-215 ° C IR (in KBr): 1630, 1535 cm -1 .
    • Example 27
      • 2- (3-methyl-1-octadecylureido) ethanol phosphocholine
        analogous to example 26 from:
        • 0.5 g 2-octadecylaminoethanol phosphocholine
        • 0.11 g of methyl isocyanate
        • 10 ml chloroform.
      • Yield: 0.35 g with mp. 219-220 ° C IR (in KBr): 1625.1540 cm -1 .
    • Example 28
      • 2- (3-methyl-1-octadecylthioureido) ethanol phosphocholine
        analogous to example 26 from:
        • 0.5 g 2-octadecylaminoethanol phosphocholine
        • 0.15 g methyl isothiocyanate
        • 10 ml chloroform.
      • Yield: 0.41 g with mp. 215-217 ° C.
    • Example 29
      • 2- (3,3-Dimethyl-1-octadecylureido) ethanol phosphocholine.
      • 0.5 g of 2-octadecylaminoethanolphosphocholine are dissolved in 10 ml of chloroform, 0.21 g of dimethylcarbamoyl chloride and 0.14g of silver carbonate are added to the solution and the mixture is stirred for about 12 hours at room temperature. The solution is concentrated in vacuo and the residue is purified by column chromatography (silica gel / chloroform / methanol / water).
      • Yield: 0.31 g with mp. 215-216 ° c IR (in KBr) 1634cm -1 .
    • Example 30
      • 2- (3-butyl-1-octadecylureido) ethanol phosphocholine
        analogous to example 26 from:
        • 0.5 g 2-octadecylaminoethanol phosphocholine
        • 0.2 g butyl isocyanate
        • 10 ml chloroform.
      • Yield: 0.38 g with mp. 208-210 ° C IR (in KBr): 1625, 1530 cm -1 .
    • Example 31
      • 2- (3-Hexadecyl-1-octadecylureido) ethanol phosphocholine
        analogous to example 26 from:
        • 0.5 g 2-octadecylaminoethanol phosphocholine
        • 0.6 g hexadecyl isocyanate
        • 10 ml chloroform.
      • Yield: 0.63 g with mp 200-203 ° C IR (in KBr): 1625, 1535cm -1 .
    • Example 32
      • 2- (3-benzyl-1-octadecylureido) ethanol phosphocholine
        analogous to example 26 from:
        • 0.5 g 2-octadecylaminoethanol phosphocholine
        • 0.27 g benzyl isocyanate
        • 10 ml chloroform.
      • Yield: 0.42 g with mp 221-222 ° C.
    • Example 33
      • 2- (3-methyl-1-undecylureido) ethanol phosphocholine
        analogous to example 26 from:
        • 0.5 g of 2-undecylaminoethanolphosphocholine
        • 0.15 g methyl isocyanate
        • 10 ml chloroform.
      • Yield: 0.3 g waxy substance with a clear point of ~ 185 ° C
        • IR (in KBr): 1629, 1540 cm -1 .
    • Example 34
      • 2- (3-ethyl-1-undecylureido) ethanol phosphocholine
        analogous to example 26 from:
        • 0.5 g of 2-undecylaminoethanolphosphocholine
        • 0.18 g of ethyl isocyanate
        • 10 ml chloroform.
      • Yield: 0.3g waxy substance with a clear point ~ 180-183 ° C
        • IR (in KBr): 1626, 1536 cm -1 .
    • Example 35
      • 2- (3,3-Dimethyl-1-undecylureido) ethanol phosphocholine
        analogous to example 29 from:
        • 0.5 g of 2-undecylaminoethanolphosphocholine
        • 0.28 g dimethyl carbamic acid chloride
        • 0.18 g silver carbonate
        • 10 ml chloroform.
      • Yield: 0.32 waxy substance with clear point: 203-204 ° C
        • IR (in KBr): 1634cm -1 .
    • Example 36
      • 2- (3-methyl-1-undecylthioreido) ethanol phosphocholine
        analogous to example 26 from:
        • 0.5 g of 2-undecylaminoethanolphosphocholine
        • 0.19 g methyl isothiocyanate
        • 10 ml chloroform.
      • Yield: 0.33 g waxy substance with a clear point of ~ 165 ° C.
    • Example 37
      • 2- (3-phenyl-1-undecylureido) ethanol phosphocholine
        analogous to example 26 from:
        • 0.5 g of 2-undecylaminoethanolphosphocholine
        • 0.31 g phenyl isocyanate
        • 10 ml chloroform.
      • Yield: 0.61 g waxy substance IR (in KBr): 1649.1538 cm -1 .
    • Example 38
      • 2- (3-benzyl-1-undecylureido) ethanol phosphocholine
      • analogous to example 26 from:
        • 1.5 g of 2-undecylaminoethanol phosphocholine
        • 1.1 g benzyl isocyanate
        • 30 ml chloroform.
      • Yield: 1.7 g waxy substance IR (in KBr): 1533.1628 cm -1 .
    • Example 39
      • 2- (3-Hexadecyl-1-undecylureido) ethanol phosphocholine
        analogous to example 26 from:
        • 0.5 g of 2-undecylaminoethanolphosphocholine
        • 0.7 g hexadecyl isocyanate
        • 10 ml chloroform.
      • Yield: 0.69 with mp 196-199 ° C IR (in KBr): 1622.1533 cm- i.
    • Example 40
      • 2- (3-oleyl-1-undecylureido) ethanol phosphocholine
        analogous to example 26 from:
        • 0.5 g of 2-undecylaminoethanolphosphocholine
        • 0.8 g oleyl isocyanate
        • 10 ml chloroform under nitrogen.
      • Yield: 0.61 g of waxy substance.
    • Example 41
      • 2- (1-Hexadecyl-3-methylureido) ethanol phosphocholine
        analogous to example 26 from:
        • 0.3 g of 2-hexadecylaminoethanol phosphocholine
        • 0.08 g methyl isocyanate
        • 5 ml chloroform.
      • Yield: 0.22 g with mp. 215-218 ° C IR (in KBr): 1635, 1540 cm -1 .
    • Example 42
      • 2- (3-ethyl-1-hexadecylureido) ethanol phosphocholine
        analogous to example 26 from:
        • 0.5 g 2-hexadecylaminoethanol phosphocholine
        • 0.15 g ethyl isocyanate
        • 10 ml chloroform.
      • Yield: 0.45 g with mp. 213-217 ° C.
    • Example 43
      • 2- (1-Hexadecyl-3-methylthioureido) ethanol phosphocholine
        analogous to example 26 from:
        • 0.5 g 2-hexadecylaminoethanol phosphocholine
        • 0.16 g methyl isothiocyanate
        • 10 ml chloroform.
      • Yield: 0.2 g with mp 210-212 ° C.
    • Example 44
      • 2- (3,3-Dimethyl-1-hexadecylureido) ethanol phosphocholine
        analogous to example 29 from:
        • 0.3 g of 2-hexadecylaminoethanol phosphocholine
        • 0.24 g of dimethyl carbamic acid chloride
        • 0.1 g silver carbonate
        • 5 ml chloroform.
      • Yield: 0.15 g with mp. 208-211 ° C IR (in KBr): 1635 cm -1 .
    • Example 45
      • 3- (3-methyl-1-octadecylureido) propanol (1) phosphocholine
        analogous to example 26 from:
        • 0.5 g 3-octadecylamino-propanol- (1) -phosphocholine
        • 0.11 g of methyl isocyanate
        • 10 ml chloroform.
      • Yield: 0.43 g with mp 221-224 ° C IR (in KBr): 1628.1540 cm- i.
    • Example 46
      • 3- (3-ethyl-1-octadecyiureido) propanol (1) phosphocholine
        analogous to example 26 from:
        • 0.5 g 3-octadecylamino-propanol- (1) -phosphocholine
        • 0.14 g of ethyl isocyanate
        • 10 ml chloroform.
      • Yield: 0.3 g with mp. 215-218 ° C IR (in KBr): 1626, 1535cm -1 .
    • Example 47
      • 3- (3,3-Dimethyl-1-octadecylureido) propanol (1) phosphocholine
        analogous to example 29 from:
        • 0.5 g 3-octadecylamino-propanol- (1) -phosphocholine
        • 0.18 g dimethyl carbamic acid chloride
        • 0.14 g of silver carbonate
        • 10 ml chloroform.
      • Yield: 0.28 g with mp. 224-225 ° C IR (in KBr): 1633 cm -1 .
    • Example 48
      • 3- (3-methyl-1-octadecylthioureido) propanol (1) phosphocholine
        analogous to example 26 from:
        • 0.5 g 3-octadecylamino-propanol- (1) -phosphocholine
        • 0.15 g methyl isothiocyanate
        • 10 ml chloroform.
      • Yield: 0.36 g with mp 210-212 ° C.
    • Example 49
      • 4- (3-methyl-1-octadecylureido) butanol (1) phosphocholine
        analogous to example 26 from:
        • 0.5 g of 4-octadecylamino-butanol (1) phosphocholine
        • 0.11 g of methyl isocyanate
        • 10 ml chloroform.
      • Yield: 0.4 g with mp 226-230 ° C IR (in KBr): 1629.1541 cm -1 .
    • Example 50
      • 4- (3-ethyl-1-octadecylureido) butanol (1) phosphocholine
        analogous to example 26 from:
        • 0.3 g of 4-octadecylamino-butanol (1) phosphocholine
        • 0.1 g ethyl isocyanate
        • 5 ml chloroform.
      • Yield: 0.25 g with mp. 215-216 ° C IR (in KBr): 1623, 1532cm -1 .
    • Example 51
      • 4- (3,3-dimethyl-1-octadecyl) butanol (1) phosphocholine
        ananolg Example 29 from:
        • 0.3 g of 4-oxadecylamino-butanol (1) phosphocholine
        • 0.13 g of dimethyl carbamic acid chloride
        • 0.1 g silver carbonate
        • 5 ml chloroform.
      • Yield: 0.15 g with mp. 234-236 ° C IR (in KBr): 1632 cm- '.
    • Example 52
      • 4- (3-methyl-1-octadecylthioureido) butanol (1) phosphocholine
        analogous to example 26 from:
        • 0.3 g of 4-octadecylamino-butanol (1) phosphocholine
        • 0.1 g methyl isothiocyanate
        • 10 ml chloroform.
      • Yield: 0.21 g with mp 221-224 ° C.
    • Example 53
      • 2- (1-eicosyl-3-methylureido) ethanol phosphocholine
        analogous to example 26 from:
        • 0.5 g of 2-eicosylaminoethanolphosphocholine
        • 0.11 g of methyl isocyanate
        • 10 ml chloroform.
      • Yield: 0.35 g with mp. 222-224 ° C.
    • Example 54
      • 2- (1-eicosyl-3-ethylureido) ethanol phosphocholine
        analogous to example 26 from:
        • 0.5 g of 2-eicosylaminoethanolphosphocholine
        • 0.14g ethyl isocyanate
        • 10 ml chloroform.
      • Yield: 0.4 g with mp. 218-220 ° C.
    • Example 55
      • 2- (3,3-Dimethyl-1-eicosylureido) ethanol phosphocholine
        analogous to example 29 from:
        • 0.5 g of 2-eicosylaminoethanolphosphocholine
        • 0.21 g of dimethyl carbamic acid chloride
        • 0.14g silver carbonate
        • 10 ml chloroform.
      • Yield: 0.3 g with mp. 215-217 ° C.
    • Example 56
      • 2- (1-eicosyl-3-methylthioureido) ethanol phosphocholine
        analogous to example 26 from:
        • 0.5 g of 2-eicosylaminoethanolphosphocholine
        • 0.15 g methyl isothiocyanate
        • 10 ml chloroform.
      • Yield: 0.3 g with mp 210-211 ° C.
    • Example 57
      • 2- (1-undecylureido) ethanol-phosphocholine analogous to Example 17 from:
        • 1.2 g of 2- (3-benzyl-1-undecylureida) ethanol phosphocholine and
        • 0.72 g Pd activated carbon, which are added in 6 portions within 20 h, in dioxane / water = 4: 1 (V / V).
      • Yield: 0.5 g waxy substance IR (in KBr): 1652.1597 cm- 1 .
    • Example 58
      • [2- (3-methyl-1-octadecylureido) ethyl] - (2-triethylammonioethyl) phosphate
        analogous to example 26 from:
        • 0.5 g (N-octadecyl-2-aminoethyl) -2-triethylam monioethyl phosphate
        • 0.11 g of methyl isocyanate
        • 10 ml chloroform,
      • Yield: 0.41 g with mp. 220-221 ° C.
    • Example 59
      • [2- (3-methyl-1-octadecylureido) ethyl] - (2-dimethylammonioethyl) phosphate
        analogous to example 26 from:
        • 0.5 g (N-octadecyl-2-aminoethyl) -2-dimethylam monioethyl phosphate
        • 0.11 g of methyl isocyanate
        • 10 ml chloroform.
      • Yield: 0.35 g with mp. 215-216 ° C.
    • Example 60
      • 2- (3-nexadecyl-1-methylureido) ethanol phosphocholine.
      • 0.5 g of 2-methylamino-ethanol-phosphocholine are dissolved in 10 ml of N-methylacetamide, the solution is mixed with 1.08 g of hexadecyl isocyanate and stirred for 24 hours at room temperature. The solution is concentrated in vacuo and the residue by column chromatography (silica gel // chloroform / methanol / water)
      • cleaned.
      • Yield: 0.3 g with mp 210-213 ° C.
      • The following are prepared as in Example 60:
        • 2- (1-methyl-3-octadecylureido) ethanol phosphocholine
        • 2- (3-eicosyl-1-methylureido) ethanol phosphocholine
        • 2- (1-methyl-3-oleylureido) ethanol phosphocholine
    • Example 61
      • N-methoxycarbonyl-N-octadecyl-2-aminoethanol (1) phosphocholine.
      • 50 mg of N-octadecyl-2-aminoethanol- (1) -phosphocholine are dissolved in 2 ml of chloroform, 20mg methyl chloroformate and 5 drops triethylamine added. The mixture is stirred for one hour at room temperature, concentrated in vacuo and the residue is purified by column chromatography (silica gel // chloroform / methanol / water).
      • Yield: 41 mg of waxy substance IR (in KBr): 1692 cm -1 .
    • Example 62
      • N-ethoxycarbonyl-N-octadecyl-2-aminoethanol (1) phosphocholine
        anaolg example 61 from:
        • 50 mg of N-octadecyl-2-aminoethanol (1) phosphocholine
        • 20 mg ethyl chloroformate
        • 5 drops of triethylamine
        • in 2 ml chloroform.
      • Yield: 39 mg of waxy substance IR (in KBr): 1690 cm -1 .
    • Example 63
      • N-Benzyloxycarbonyl-N-octadecyl-2-aminoethanol- (1) -phosphocholine analogously to Example 61 from:
        • 50 mg of N-octadecyl-2-aminoethanol (1) phosphocholine
        • 34 mg benzyl chloroformate
        • 5 drops of triethylamine
        • in 2 ml chloroform.
      • Yield: 55 mg with mp. 211 ° C.

Claims (18)

1. Substituted aminoalkanol phospholipids of the general formula I
Figure imgb0048
in which
X represents an oxygen or a sulphur atom and
Y the radical-NR1R2 or-OR3,

wherein
R1, R2 can be the same or different and represent a saturated or unsaturated straight-chained ε branched alkyl radical having 1 to 20 carbon at oms, a benzyl radical, a phenyl radical or hydro gen,
R3 represents phenyl, benzyl or C1-4-alkyl,
R4, R5, R6 can be the same or different and re present hydrogen or a low alkyl radical having to 4 carbon atoms,
I represents an integerfrom 0 to 19,
m represents an integer from 2 to 6,
n represents an integer from 2 to 4.
2. Substituted aminoalkanol phospholipids according to claim 1 in which
X represents an oxygen or a sulphur atom and
Y the radical-NR1R2,

wherein
R1, R2 can be the same or different and represent a saturated or an unsaturated, straight-chained or branched alkyl radical having 1 to 20 carbon atoms, a benzyl radical, a phenyl radical or hydrogen,
R4, R5, R6 can be the same or different and represent hydrogen or a low alkyl radical having 1 to 4 carbon atoms,
I represents an integer from 0 to 19,
m represents an integer from 2 to 6, and
n represents an integer from 2 to 4.
3. Substituted aminoalkanol phosphocholines according to claim 1, in which
X represents an oxygen or a sulphur atom and
Y the radical NR1R2,

wherein
R1, R2 can be the same or different and represent an alkyl radical having 1 to 20 carbon atoms, R4, R5, R6 each represent a methyl group,
I an integer from 0 to 19,
m an integer from 2 to 6, and
n represents 2.
4. Substituted aminoalkanol phospholipids according to claim 1, in which
X represents an oxygen atom and
Y the radical -OR3,

wherein
R3 represents phenyl, benzyl or C1-4-alkyl,
R4, R5, R6 can be the same or different and represent hydrogen or a low alkyl radical having 1 to 4 carbon atoms,
I represents an integer from 0 to 19,
m an integer from 2 to 6, and
n an integerfrom 2 to 4.
5. Substituted aminoalkanol phosphocholines according to claim 1, in which
X represents an oxygen atom and
Y the radical -OR3,

wherein
R3 represents benzyl or C1-4-alkyl,
R4, R5, R6 each represent a methyl group,
I represents an integer from 0to 19,
m an integer from 2to 6, and
n represents 2.
6. A method of producing compounds according to any of claims 1 to 3, in which compounds of the general formula X
Figure imgb0049
wherein R4, R5, R6, I, m, n represent the same as in formula I, are reacted in a manner known per se with carbonic acid derivatives of formula XI or XII
Figure imgb0050
Figure imgb0051
wherein R1, R2, X represent the same as in Formula I, with or without the presence of an inert organic solvent, possibly with the addition of a catalyst or of an auxiliary base, in particular when compounds of formula XII are used.
7. A method of producing compounds according to any of claims 1 to 3, in which N-alkyl-aminoalkanols of the general formula II
Figure imgb0052
are reacted with benzyl halides or chloroformic acid benzyl esters to form compounds of formula III
Figure imgb0053
wherein R7 represents a radical which may be separated by hydrogenation such as, for exem- ple, benzyl or benzyloxy carbonyl, and the compounds III are phosphorylated according to processes known per se by reacting with dichlorophosphoric acid-ω-alkyl halide esters and then converted by reacting with amines NR4R5R6 to form the compounds of formula IV
Figure imgb0054
which are hydrogenated according to methods known per se to form the compounds of formula X and are reacted with the carbonic acid derivatives of formula XI or XII.
8. A method of producing compounds according to any of claims 1 to 3 in which R1 = R2 = H and X = 0 in formula I, in which compounds of formula I in which R1 = benzyl, R2 = H and X = 0, are hydrogenated in an inert organic solvent in the presence of a conventional hydrogenation catalyst.
9. A method of producing compounds of formula X according to claim 6, in which compounds offormula IV
Figure imgb0055
wherein R4, R5, R6, I, m, n represent the same as in formula I and R7 represents a radical separable by hydrogenation, such as, for example, benzyl or benzyloxy carbonyl, are hydrogenated in an inert organic solvent with the use of a conventional hydrogenation catalyst.
10. A method for producing compounds of formula IV according to claim 7, in which N,N-disubstituted aminoalkanols of formula III
Figure imgb0056
in which I, m and R7 represent the same as in formula IV, are phosphorylated with a dichlorophosphoric acid-ω-alkyl halide ester of formula V
Figure imgb0057
wherein n represents the same as in formula I and Hal represents a chlorine or a bromine atom, in an inert organic solvent, optionally with the use of an auxiliary base, and then reacting the products with an amine of formula VI
Figure imgb0058
wherein R4, R5, R6 are the same as in formula I, in an inert organic solvent, optionally under pressure.
11. A method of producing compounds of formula IV according to claim 7, in which compounds of formula III according to claim 10 are phosphorylated with phosphorus oxytrichloride and then allow the product to react with an alkane diol of formula VII
Figure imgb0059
in which n is the same as in formula I, possibly with the introduction of auxiliary bases and inert solvents to form the cyclic phosphor compounds of formula VIII
Figure imgb0060
in which I, m, n represent the same as in formula I and R7 represents the same as in formula IV, and to then allow the compounds of formula VIII to react with an amine of formula VI according to claim 10 in an organic solvent, optionally under pressure.
12. A method of producing compounds fo formula VIII according to claim 11, in which compounds of formula III according to claim 10 are reacted with a cyclic phosphor compound of formula IX
Figure imgb0061
wherein n represents the same as in formula I, in an inert organic solvent with the addition of an auxiliary base.
13. A method of producing compounds of formula III according to claim 10, in which N-alkylamino alkanols of formula II
Figure imgb0062
wherein I and m are the same as in formula I are reacted with a benzyl halide or a chloroformic acid benzyl ester in an inert organic medium, optionally with the addition of an auxiliary base.
14. A method of producing compounds according to any of claims 1, 4 and 5, in which disubstituted amino alcohols of formula XIII
Figure imgb0063
wherein R3, l and m are the same as in formula I, are phosphorylated with a dichlorophosphoric acid-ω-alkyl halide ester of formula V according to claim 10 in an inert organic solvent, optionally with the use of an auxiliary base, and the product is then reacted with an amine of formula VI according to claim 10 in an inert organic solvent, optionally under pressure.
15. A method of producing compounds according to any of claims 1,4 and 5, in which compounds of formula XIII according to claim 14 are converted by phosphorylation with phosphorus oxytrichloride and subsequent reaction with an alkane diol of formula VII according to claim 11 optionally with the introduction of auxiliary bases and inert solvents, to the cyclic phosphor compounds of formula XIV
Figure imgb0064
wherein R3, I, m and n are the same as in formula I, and the compound XIV is subsequently allowed to react with an amine of formula VI according to claim 10 in an organic solvent, optionally under pressure.
16. A method of producing compounds according to any of claims 1, 4 and 5, in which compounds of formula XIII according to claim 14 are reacted with cyclic phosphor compounds of formula IX according to claim 12 in an inert organic solvent with the addition of an auxiliary base.
17. A method of producing compounds of formula XIII according to claim 14, in which N-alkylamino alkanols of formula II according to claim 7 are reacted with chloroformic acid esters in an inert organic medium, optionally with the addition of an auxiliary base.
18. Amethod of producing compounds according to any of claims 1, 4 and 5, wherein amino alkanol phospholipids of formula X according to claim 6 are reacted with chloroformic acid esters in an inert organic medium, optionally with the addition of an auxiliary base.
EP83109927A 1982-10-25 1983-10-05 Substituted aminoalcanol phospholipids and process for their preparation Expired EP0107120B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AT83109927T ATE23164T1 (en) 1982-10-25 1983-10-05 SUBSTITUTED AMINOALKANOLPHOSPHOLIPIDES AND PROCESS FOR THEIR PRODUCTION.

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
DE3239388 1982-10-25
DE19823239390 DE3239390A1 (en) 1982-10-25 1982-10-25 Novel (aryl)alkyloxycarbonylaminoalkylphosphocholines, and processes for their preparation
DE3239390 1982-10-25
DE19823239388 DE3239388A1 (en) 1982-10-25 1982-10-25 Ureidoalkanolphosphocholines and process for their preparation

Publications (2)

Publication Number Publication Date
EP0107120A1 EP0107120A1 (en) 1984-05-02
EP0107120B1 true EP0107120B1 (en) 1986-10-29

Family

ID=25805325

Family Applications (1)

Application Number Title Priority Date Filing Date
EP83109927A Expired EP0107120B1 (en) 1982-10-25 1983-10-05 Substituted aminoalcanol phospholipids and process for their preparation

Country Status (3)

Country Link
US (1) US4565659A (en)
EP (1) EP0107120B1 (en)
DE (1) DE3367219D1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS638391A (en) * 1986-06-27 1988-01-14 Terumo Corp Polymerizable beta-glycerophospholipid and production thereof
EP1745788A1 (en) 2005-07-22 2007-01-24 KTB Tumorforschungsgesellschaft mbH Acyglycerophospholipids for treating cancer and cachexia
EP3895709A1 (en) 2020-04-17 2021-10-20 Andreas Hettich GmbH & Co. KG Phospholipids and phospholipid metabolites for the treatment of viral and bacterial lung inflammation and sepsis

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2820893C2 (en) * 1978-05-12 1986-02-20 A. Nattermann & Cie GmbH, 5000 Köln Structural analogs of natural phospholipids and processes for making these compounds
DE3127503A1 (en) * 1981-07-11 1983-02-17 Boehringer Mannheim Gmbh, 6800 Mannheim NEW PHOSPHOLIPIDS, METHOD FOR THE PRODUCTION THEREOF, AND MEDICINAL PRODUCTS CONTAINING THESE COMPOUNDS

Also Published As

Publication number Publication date
US4565659A (en) 1986-01-21
DE3367219D1 (en) 1986-12-04
EP0107120A1 (en) 1984-05-02

Similar Documents

Publication Publication Date Title
DE68904104T2 (en) PHENOL-SUBSTITUTED GEM-DIPHOSPHONATE DERIVATIVES, PROCESS FOR THEIR PRODUCTION AND MEDICINAL PRODUCTS CONTAINING THE SAME.
DE3307925A1 (en) NEW 0-ACYL-ALKANDIOL PHOSPHOLIPIDS, METHOD FOR THE PRODUCTION THEREOF AND PHARMACEUTICAL PREPARATIONS CONTAINING THEM
EP0036583B1 (en) Glycerine-3-phosphoric acid halogenalkyl ester, process for its preparation and further processing
EP0154977B1 (en) Glycerin-ether phosphatides, their preparation and use
EP0007490B1 (en) Prostaglandin compounds with a delta-2,4-11 deoxy pge structure, a process for their preparation, and their use as medicaments
EP0107120B1 (en) Substituted aminoalcanol phospholipids and process for their preparation
EP0072531A1 (en) Derivatives of cyclophosphamide, process for their preparation and their use
EP0338407B1 (en) New alkylphosphonoserines, methods for preparing them, and pharmaceutical substances containing them
EP0002062B1 (en) Cyclic organophosphorus compounds, method for their preparation and their use
EP0521353B1 (en) Antineoplastic medicament containing octadecyl-[2-(N-methylpiperidino)-ethyl] phosphate and synthesis thereof
EP0098601A1 (en) Derivatives of N.N-bis-(2-chloro-ethyl)-phosphoric-acid amides
DE4030587A1 (en) METHOD FOR PRODUCING D-MYOINOSITE-1-PHOSPHATE
EP0229128B1 (en) Derivatives of glycero-3(2)-phospho-l-serine and pharmaceutical preparations containing them
DE3323871A1 (en) NEW 1-O-ALKYL-3-AMINO-PROPAN-1,2-DIOL-2-O-PHOSPHOLIPIDES, METHOD FOR THE PRODUCTION THEREOF AND PHARMACEUTICAL PREPARATIONS CONTAINING THEM
DE2345060C3 (en) 1,2-dialkyl ketone glycerol-3-phosphatide and process for their preparation
DE3239388A1 (en) Ureidoalkanolphosphocholines and process for their preparation
DE3239390A1 (en) Novel (aryl)alkyloxycarbonylaminoalkylphosphocholines, and processes for their preparation
WO2002076515A2 (en) Method of producing 1-hydroxy-1,1-diphosphonic acid compounds
DE3133309C2 (en)
DE3212387A1 (en) Glycerol phosphatides, processes for their preparation and their use in medicaments
EP0663918A1 (en) Pure enantiomers of phosphoric-acid esters as phospholipase-a2 inhibitors
DE2640692C3 (en) Optically active 5- (2-carboxythiophen5-yl) -16phenoxy- a -tetranor- w tetranor-prostaglandins
DD152563A5 (en) PROCESS FOR PREPARING ALPHA-OXO-ALPHA- (3-ALKOXYCARBONYL-2,2-DIMETHYL-CYCLOPROP-1-YL) METHANE PHOSPHONIC ACID ESTERS
DD258985A1 (en) METHOD FOR PRODUCING NEW BENZOYL-TRIAZOLYL-ACETIC ACID OR THIOUSY ACID DERIVATIVES
EP0001255A1 (en) Fluorinated prostaglandine derivatives, a process for their preparation and their use as a drug

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

AK Designated contracting states

Designated state(s): AT BE CH DE FR GB IT LI LU NL SE

17P Request for examination filed

Effective date: 19840524

GRAA (expected) grant

Free format text: ORIGINAL CODE: 0009210

AK Designated contracting states

Kind code of ref document: B1

Designated state(s): AT BE CH DE FR GB IT LI LU NL SE

REF Corresponds to:

Ref document number: 23164

Country of ref document: AT

Date of ref document: 19861115

Kind code of ref document: T

ITF It: translation for a ep patent filed

Owner name: ING. C. GREGORJ S.P.A.

REF Corresponds to:

Ref document number: 3367219

Country of ref document: DE

Date of ref document: 19861204

ET Fr: translation filed
PLBE No opposition filed within time limit

Free format text: ORIGINAL CODE: 0009261

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT

26N No opposition filed
PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: LU

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 19871031

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: NL

Payment date: 19871031

Year of fee payment: 5

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: GB

Effective date: 19891005

Ref country code: AT

Effective date: 19891005

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: SE

Effective date: 19891006

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: LI

Effective date: 19891031

Ref country code: CH

Effective date: 19891031

Ref country code: BE

Effective date: 19891031

BERE Be: lapsed

Owner name: A. NATTERMANN & CIE G.M.B.H.

Effective date: 19891031

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: NL

Effective date: 19900501

GBPC Gb: european patent ceased through non-payment of renewal fee
NLV4 Nl: lapsed or anulled due to non-payment of the annual fee
PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: FR

Effective date: 19900629

REG Reference to a national code

Ref country code: CH

Ref legal event code: PL

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: DE

Effective date: 19900703

REG Reference to a national code

Ref country code: FR

Ref legal event code: ST

EUG Se: european patent has lapsed

Ref document number: 83109927.0

Effective date: 19900706